WO1999052025A2 - Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens - Google Patents

Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens Download PDF

Info

Publication number
WO1999052025A2
WO1999052025A2 PCT/US1999/007171 US9907171W WO9952025A2 WO 1999052025 A2 WO1999052025 A2 WO 1999052025A2 US 9907171 W US9907171 W US 9907171W WO 9952025 A2 WO9952025 A2 WO 9952025A2
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic treatment
information
patient
medical condition
disease
Prior art date
Application number
PCT/US1999/007171
Other languages
French (fr)
Other versions
WO1999052025A3 (en
Inventor
David W. Barry
Carolyn S. Underwood
Bruce J. Mccreedy
David D. Hadden
Jason L. Lucas
Original Assignee
Triangle Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22158589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1999052025(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Triangle Pharmaceuticals, Inc. filed Critical Triangle Pharmaceuticals, Inc.
Priority to AU34617/99A priority Critical patent/AU750822B2/en
Priority to CA2326579A priority patent/CA2326579C/en
Priority to BR9909906-3A priority patent/BR9909906A/en
Priority to IL13862099A priority patent/IL138620A0/en
Priority to JP2000542701A priority patent/JP2002510817A/en
Priority to EP99916262A priority patent/EP1068568A4/en
Publication of WO1999052025A2 publication Critical patent/WO1999052025A2/en
Publication of WO1999052025A3 publication Critical patent/WO1999052025A3/en

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/20ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/60ICT specially adapted for the handling or processing of medical references relating to pathologies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S706/00Data processing: artificial intelligence
    • Y10S706/902Application using ai with detail of the ai system
    • Y10S706/924Medical

Definitions

  • This invention concerns systems, methods and computer program products for guiding the selection of therapeutic treatment regimens for complex disorders such as cancer and HIV-1 infection, wherein a ranking of available treatment regimens is generated and advisory information clinically useful for treating patients is provided.
  • Therapeutic treatment regimens for disorders such as HIV-1 infection (acquired immune deficiency syndrome or AIDS) and cancer are increasingly complex. New data and new therapeutic treatment regimens continue to modify the treatments available, and it is difficult for all but the specialist to remain current on the latest treatment information. Further, even those who are current on the latest treatment information require time to assimilate that information and understand how it relates to other treatment information in order to provide the best available treatment for a patient. Combination therapeutic treatment regimens exacerbate this problem by making potential drug interactions even more complex. Finally, an increasingly sophisticated patient population, in the face of a vast volume of consumer information on the treatment of disease, makes the mere statement of a treatment regime, without explanation, difficult for the patient to accept.
  • U.S. Patent No. 5,672,154 to Sillen describes a method for giving patients individualized, situation- dependent medication advice.
  • the recommended type of medicine may include at least two different medicines.
  • No means for ranking multiple treatment options is disclosed, and no means for explaining why treatment options were rejected is given. Rather, this system is primarily concerned with generating new rules from patient information to optimize a particular therapy for diseases such as Parkinson's disease, epilepsy and abnormal blood pressure .
  • U.S. Patent No. 5,694,950 to McMichael describes a method and system for use in treating a patient with immunosuppressants such as cyclosporin.
  • An expert system is employed to generate a recommendation on whether the immunosuppressant dosage should be changed and, if so, how. Ranking or selection among a plurality of different combination therapeutic treatment regimens is not suggested.
  • U.S. Patent No. 5,594,638 to Iliff describes a medical diagnostic system that provides medical advice to the general public over a telephone network. This system is not concerned with generating a recommendation for a combination therapeutic treatment regimen for a known disease (see also U.S. Patent No. 5,660,176 to Iliff) .
  • an object of the invention is to provide systems, methods and computer program products for selecting therapeutic treatment regimens for patients in which available treatments are listed, and optionally ranked, while unavailable or rejected treatment regimens (e.g., regimens that would not be effective, or would be dangerous) are not displayed or are assigned a low rank and are indicated to a user as not likely to be efficacious, or not preferred due to patient-specific complicating factors such as drug interaction from concomitant medications.
  • unavailable or rejected treatment regimens e.g., regimens that would not be effective, or would be dangerous
  • a further object of the invention is to provide systems, methods and computer program products for selecting treatment regimens in which the available treatment options can be readily understood.
  • a further object of the invention is to provide systems, methods and computer program products for selecting treatment regimens in which the implications of selecting a particular treatment regimen can be readily understood.
  • a further object of the invention is to provide systems, methods and computer program products for selecting treatment regimens in which the reasons for rejection of a particular regimen can be readily understood.
  • a still further object of the invention is to provide systems, methods and computer program products for obtaining information about the efficacy of previous treatment regimens imposed on patients.
  • a method of the present invention includes providing patient information to a computing device that includes various knowledge bases.
  • a first knowledge base may include a plurality of different therapeutic treatment regimens for a disease or medical condition.
  • a second knowledge base may include a plurality of expert rules for selecting a therapeutic treatment regimen for the disease or medical condition.
  • a third knowledge base may include advisory information useful for the treatment of a patient with different constituents of different therapeutic treatment regimens.
  • a fourth knowledge base may include information about past therapies, such as how a patient has fared under previous therapies.
  • a listing (preferably a ranked listing) of therapeutic treatment regimens for a patient is generated in the computing device.
  • Advisory information for one or more treatment regimens in the listing is generated in the computing device based on the patient information and the expert rules .
  • the method described above further includes entering a user- defined therapeutic treatment regimen for the disease (or medical condition) that may not be displayed from the system knowledge base-generated therapeutic treatment regimens, and generating in the computing device advisory information for the user-defined combination therapeutic treatment regimen.
  • the method described above further includes entering a rejected therapeutic treatment regimen for the disease (or medical condition) that is included in the first knowledge base but not recommended from the ranking (or given a very low ranking) , and generating in the computing device advisory information for the non- recommended/low ranked therapeutic treatment regimen, wherein the advisory information includes at least one reason for not recommending (or low ranking) the therapeutic treatment regimen.
  • Fig. 1 illustrates a process of the instant invention, including routines for entering a user- defined therapeutic treatment regimen and for entering a "non-recommended" therapeutic treatment regimen.
  • Fig. 2 schematically illustrates a system or apparatus of the present invention.
  • Fig. 3 illustrates a client-server environment within which the system of Fig. 2 may operate, according to an embodiment of the present invention, and wherein a central server is accessible by at least one local server via a computer network, such as the Internet, and wherein each local server is accessible by at least one client.
  • a central server is accessible by at least one local server via a computer network, such as the Internet, and wherein each local server is accessible by at least one client.
  • Fig. 4 illustrates a medical history user interface for entering data about a patient ' s medical history according to the present invention.
  • Fig. 5 illustrate a user interface chart for monitoring a patient's condition during a particular therapeutic treatment regimen over a period of time according to the present invention.
  • Fig. 6 illustrates a therapy evaluation user interface that facilitates evaluation of various therapeutic treatment regimen options with respect to relative efficacy, individualized adjusted relative efficacy, dosage, frequency, cost, medical complications and drug interactions according to the present invention.
  • Fig. 7 illustrates various symbols for providing information about a therapeutic treatment regimen option within the therapy list box of the therapy evaluation user interface of Fig. 6 according to the present invention.
  • Fig. 8 illustrates the therapy details box of Fig. 6 in "full screen” mode.
  • Fig. 9 illustrates a pop-up menu including an indexed electronic link to a PDR® that can be activated from within the therapy list box of the therapy evaluation user interface of Fig. 6 according to the present invention.
  • Figs. 10A-10D illustrate various functions of the present invention as described in Example 1.
  • Figs. 11A-11E illustrate various functions of the present invention as described in Example 2.
  • Figs. 12A-12C illustrate various functions of the present invention as described in Example 3.
  • the present invention may be embodied as a method, data processing system, or computer program product. Accordingly, the present invention may take the form of an entirely hardware embodiment, an entirely software embodiment, or an embodiment combining software and hardware aspects. Furthermore, the present invention may take the form of a computer program product on a computer-usable storage medium having computer readable program code means embodied in the medium. Any suitable computer readable medium may be utilized including, but not limited to, hard disks, CD-ROMs, optical storage devices, and magnetic storage devices. The present invention is described below with reference to flowchart illustrations of methods, apparatus (systems) , and computer program products according to an embodiment of the invention.
  • each block of the flowchart illustrations, and combinations of blocks in the flowchart illustrations can be implemented by computer program instructions.
  • These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer or other programmable data processing apparatus, create means for implementing the functions specified in the flowchart block or blocks .
  • These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means which implement the function specified in the flowchart block or blocks.
  • the computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the functions specified in the flowchart block or blocks.
  • a method of the instant invention is illustrated in Fig. 1.
  • the patient is examined to determine patient information. Examples of patient information that may be gathered include one or more of gender, age, weight, CD4 + cell information, viral load information, HIV genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information, and information for drug treatments for other conditions.
  • the information may include historical information on prior therapeutic treatment regimens for the disease or medical condition. While the patient is typically examined on a first visit to determine the patient information, it will be appreciated that patient information may also be stored in the computing device, or transferred to the computing device from another computing device, storage device, or hard copy, when the information has been previously determined.
  • the patient information is then provided 11 to a computing device that contains a knowledge base of treatments, contains a knowledge base of expert rules for determining available treatment options for the patient in light of the patient information, and also contains a knowledge base of advisory information.
  • a list of available treatments for the patient is then generated 12 from the patient information and the available treatments by the expert rules, and advisory information for the available treatments is generated 13.
  • the advisory information may include warnings to take the patient off a contraindicated drug or select a suitable non contraindicated drug to treat the condition before initiating a corresponding treatment regimen and/or information clinically useful to implement a corresponding therapeutic treatment regimen .
  • the treatment regimen when the known disease is HIV-1 infection, the treatment regimen includes antiretroviral drugs, and the treatment regimen or advisory information may also include contraindicated or potentially adversely interacting non-antiretroviral drugs.
  • the treatment regimen includes a protease inhibitor.
  • a contraindicated drug may be terfenadine.
  • a contraindicated drug is cisapride.
  • antiretroviral drugs are listed below in Table 1.
  • Exemplary advisory information that can be displayed to a user is summarized below in Table 2 .
  • Diseases are those for which multiple different therapy options are available for selection and treatment.
  • diseases and medical conditions include, but are not limited to, cardiovascular disease (including but not limited to congestive heart failure, hypertension, hyperlipidemia and angina) , pulmonary disease (including but not limited to chronic obstructive pulmonary disease, asthma, pneumonia, cystic fibrosis, and tuberculosis) , neurologic disease (including but not limited to Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, amyotrophic lateral sclerosis or ALS, psychoses such as schizophrenia and organic brain syndrome, neuroses, including anxiety, depression and bipolar disorder) , hepatitis infections (including hepatitis B and hepatitis C infection) , urinary tract infections, venereal disease, cancer (including but not limited to breast, lung, prostate, and colon cancer), etc.
  • cardiovascular disease including but not limited to congestive heart failure, hypertension, hyperlipidemia and angina
  • pulmonary disease including but not limited to chronic ob
  • the present invention is useful for known diseases such as HIV-1 infection (acquired immune deficiency syndrome or "AIDS"), or where the known disease is any medical condition for which a combination therapeutic treatment regimen can be used.
  • the invention is particularly useful when the list of available treatments includes a plurality (e.g., 2, 10 or 15 or more) of treatment, combination therapeutic treatment regimens ⁇ e. g. , therapeutic treatment regimens incorporating two or more active therapeutic agents) , where the potential for drug interactions is increased and/or the complexity involved in selecting the best available treatment is multifactorial .
  • the list of available treatments and advisory information may be regenerated in a number of ways.
  • the patient information may be simply modified 18.
  • a user-defined therapy may be entered 14 and advisory information generated 15 based on the user- defined therapy.
  • the non-recommended therapeutic treatment regimen may be entered 16 and advisory information generated 17 for the non-recommended therapeutic treatment regimen. This may indicate to the user that they should discontinue use of a non-critical drug for another condition or select a suitable substitute that does not create a conflict/non-recommended situation so that they can then proceed with the therapy of choice.
  • the advisory information can be generated automatically for non-recommended therapeutic treatment regimens.
  • therapy and “therapeutic treatment regimen” are interchangeable herein and, as used herein, mean any pharmaceutical or drug therapy, regardless of the route of delivery (e.g., oral, intraveneous, intramuscular, subcutaneous, intraarterial, intraperitoneal, intrathecal, etc.), for any disease (including both chronic and acute medical conditions, disorders, and the like) .
  • route of delivery e.g., oral, intraveneous, intramuscular, subcutaneous, intraarterial, intraperitoneal, intrathecal, etc.
  • disease including both chronic and acute medical conditions, disorders, and the like
  • the present invention is not limited to facilitating or improving the treatment of diseases.
  • the present invention may be utilized to facilitate or improve the treatment of patients having various medical conditions, without limitation.
  • the present invention may be embodied as an expert system that provides decision support to physicians (or other health care providers) treating patients with a known disease, such as HIV infection.
  • a system according to the present invention calculates combination antiretroviral therapy options and attaches all relevant information to those options.
  • an expert system also known as artificial intelligence (Al)
  • Al artificial intelligence
  • An expert system typically contains a knowledge base containing accumulated experience and a set of rules for applying the knowledge base to each particular situation that is described to the program.
  • Expert systems are well known to those of skill in the art and need not be described further herein.
  • the antiretroviral therapy options (combinations of antiretroviral drugs) , are derived using a knowledge base consisting of a number of expert system rules and functions which in turn take into account a given patient's treatment history, current condition and laboratory values.
  • a system according to the present invention supports the entry, storage, and analysis of patient data in a large central database.
  • a system according to the present invention has a flexible data driven architecture and custom reporting capabilities designed to support patient therapy management and clinical drug trial activities such as screening, patient tracking and support. It is anticipated that a system according to the present invention may be used by health care providers (including physicians) , clinical research scientists, and possibly healthcare organizations seeking to find the most cost-effective treatment options for patients while providing the highest standard of care.
  • a system 20 for carrying out the present invention is schematically illustrated in Fig. 2.
  • the system 20 comprises a knowledge base of treatment regimens 21, which may be ranked for efficacy ( e . g. , by a panel of experts) or ranked according to system rules, a knowledge base of expert rules 22, a knowledge base of advisory information 23, a knowledge base of patient therapy history 24 and patient information 25.
  • Patient information is preferably stored within a database and is configured to be updated.
  • the knowledge bases and patient information 21-25 may be updated by an input/output system 29, which can comprise a keyboard (and/or mouse) and video monitor. Note also that, while the knowledge bases and patient data 21-25 are shown as separate blocks, the knowledge bases and patient data 21-25 can be combined together ( e . g.
  • the expert rules and the advisory information can be combined in a single database) .
  • the information from blocks 21-25 is provided to an inference engine 26, which generates the listing of available treatments and the corresponding advisory information from the information provided by blocks 21- 25.
  • the inference engine 26 may be implemented as hardware, software, or combinations thereof. Inference engines are known and any of a variety thereof may be used to carry out the present invention. Examples include, but are not limited to, those described in U.S. Patents Nos. 5,263,127 to Barabash et al . (Method for fast rule execution of expert systems); 5,720,009 to Kirk et al . (Method of rule execution in an expert system using equivalence classes to group database objects); 5,642,471 to Paillet (Production rule filter mechanism and inference engine for expert system) ;
  • the inference engine 26 may be a separate block from the knowledge bases and patient information blocks 21-25, or may be combined together in a common program or routine. Note that the advisory information that is generated for any available therapy may differ from instance to instance based on differences in the patient information provided.
  • the present invention can be implemented as a system running on a stand alone computing device .
  • the present invention is implemented as a system in a client-server environment.
  • a client application is the requesting program in a client-server relationship.
  • a server application is a program that awaits and fulfills requests from client programs in the same or other computers.
  • Client-server environments may include public networks, such as the Internet, and private networks often referred to as "intranets", local area networks (LANs) and wide area networks (WANs) , virtual private networks (VPNs) , frame relay or direct telephone connections.
  • LANs local area networks
  • WANs wide area networks
  • VPNs virtual private networks
  • a client application or server application including computers hosting client and server applications, or other apparatus configured to execute program code embodied within computer usable media, operates as means for performing the various functions and carries out the methods of the various operations of the present invention.
  • the illustrated client-server environment 30 includes a central server 32 that is accessible by at least one local server 34 via a computer network 36, such as the Internet.
  • a computer network 36 such as the Internet.
  • a variety of computer network transport protocols including, but not limited to TCP/IP, can be utilized for communicating between the central server 32 and the local servers 34.
  • the central server 32 includes a central database 38, such as the Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program, version 6.5 (available from Microsoft® SQL Server application program
  • the central server 32 ensures that the local servers 34 are running the most recent version of a knowledge base.
  • the central server 32 also stores all patient data and performs various administrative functions including adding and deleting local servers and users to the system (20, Fig. 2) .
  • the central server 32 also provides authorization before a local server 34 can be utilized by a user.
  • Patient data is preferably stored on the central server 32, thereby providing a central repository of patient data. However, it is understood that patient data can be stored on a local server 34 or on local storage media.
  • Each local server 34 typically serves multiple users in a geographical location.
  • Each local server 34 includes a server application, an inference engine, one or more knowledge bases, and a local database 39.
  • Each local server 34 performs artificial intelligence processing for carrying out operations of the present invention.
  • the user logs on to a local server 34 via a client 35, the user is preferably authenticated via an identification and password, as would be understood by those skilled in the art. Once authenticated, a user is permitted access to the system (20, Fig. 2) and certain administrative privileges are assigned to the user.
  • Each local server 34 also communicates with the central server 32 to verify that the most up-to- date version of the knowledge base(s) and application are running on the requesting local server 34. If not, the requesting local server 34 downloads from the central server 32 the latest validated knowledge base(s) and/or application before a user session is established. Once a user has logged onto the system (20, Fig. 2) and has established a user session, all data and artificial intelligence processing is preferably performed on a local server 34.
  • An advantage of the illustrated client-server configuration is that most of the computationally intensive work occurs on a local server 34, thereby allowing "thin" clients 35 (i.e., computing devices having minimal hardware) and optimizing system speed.
  • each local server database 39 is implemented via a Microsoft® SQL Server application program, Version 6.5.
  • the primary purpose of each local database 39 is to store various patient identifiers and to ensure secure and authorized access to the system (20, Fig. 2) by a user. It is to be understood, however, that both central and local databases 38, 39 may be hosted on the central server 32.
  • Each local client 35 also includes a client application program that consists of a graphical user interface (GUI) and a middle layer program that communicates with a local server 34.
  • Program code for the client application program may execute entirely on a local client 35, or it may execute partly on a local client 35 and partly on a local server 34.
  • GUI graphical user interface
  • Program code for the client application program may execute entirely on a local client 35, or it may execute partly on a local client 35 and partly on a local server 34.
  • a user interacts with the system (20, Fig. 2) by entering (or accessing) patient data within a GUI displayed within the client 35.
  • the client 35 then communicates with a local server 34 for analysis of the displayed patient information.
  • Computer program code for carrying out operations of the present invention is preferably written in an object oriented programming language such as JAVA ® , Smalltalk, or C++.
  • the computer program code for carrying out operations of the present invention may also be written in conventional procedural programming languages, such as the "C" programming language, in an interpreted scripting language, such as Perl, or in a functional (or fourth generation) programming language such as Lisp, SML, or Forth.
  • the middle layer program of the client application includes an inference engine within a local server 34 that provides continuous on-line direction to users, and can instantly warn a user when a patient is assigned drugs or a medical condition that is contraindicated with, or antagonistic of, the patient's current antiretroviral therapy. Every time patient data is entered into the system (20, Fig. 2) or updated, or even as time passes, the inference engine evaluates the current status of the patient data, sorting, categorizing, ranking and customizing every possible antiretroviral therapy for a patient according to the specific needs of the patient.
  • Each knowledge base used by an inference engine according to the present invention is a collection of rules and methods authored by a clinical advisory panel of HIV-treating physicians and scientists.
  • a knowledge base may have subjective rules, objective rules, and system-generated rules.
  • Objective rules are based on industry established facts regarding the treatment of HIV using antiretroviral therapy and are drawn from the package insert information of antiretroviral drug manufacturers and from peer reviewed and published journal articles.
  • An example of an objective rule would be an antiretroviral to antiretroviral contraindication such as :
  • rule #1 the term "eval therapy” refers to the therapy currently being analyzed by the system (20, Fig. 2) . Rule #1 then states that if this therapy contains both AZT and d4T, then this therapy should not be displayed in a list of potential therapy options for the patient.
  • the present invention can be configured so as to prevent a user from receiving recommendations on new therapy options when certain crucial data on the patient has not been entered.
  • the present invention does not prevent a health care provider, such as a physician, from recording his/her therapy decisions, even if the system (20, Fig. 2) has shown reasons why that therapy may be harmful to the patient.
  • the present invention allows a health care provider to be the final authority regarding patient therapy.
  • Subjective rules are based on expert opinions, observations and experience. Subjective rules are typically developed from "best practices" information based on consensus opinion of experts in the field. Such expert opinion may be based on knowledge of the literature published or presented in the field or their own experience from clinical practice, research or clinical trials of approved and unapproved medications. A number of experts are used so that personal bias is reduced. System generated rules are those derived from the outcomes of patients tracked in the system who received known and defined therapies and either improved, stabilized or worsened during a defined period. Because of the large number of potential combinations usable in HIV infection, this system generated database and rules derived from them are likely to encompass data beyond that achievable from objective or subjective rules databases.
  • the rules which comprise the various knowledge bases (21-24, Fig. 2) of the present invention each have two main parts : a premise and a conclusion - also referred to as the left side and the right side, respectively.
  • a premise of a rule is found to be true, the action specified in the conclusion is taken. This is known to those of skill in the art as "firing" the rule. For example, consider the following rule:
  • the premise of the above rule is for the inference engine to determine whether or not a therapy being evaluated (i.e., "eval therapy") contains the antiretroviral drug "ddC” . If a therapy does contain the antiretroviral drug ddC, the action called for by the conclusion of the rule is to attach "Commentary 18" to the therapy. Commentary 18 may be a piece of text that provides a user with the necessary information about therapies containing ddC.
  • Therapy initiation/change Rules that provide information on therapy change or initiation
  • Boundary condition rules Limits for values, intervals for values to be updated
  • Comment Data Aging rules These rules warn the user that the data in certain fields is getting old and that the most current values in the system will be used.
  • the inference engine (26, Fig. 2) can evaluate potential therapy options for a patient based on a patient's medical history (including therapy history) and current laboratory values. Accordingly multiple antiretroviral drug combinations can be quickly and accurately analyzed for a particular patient. Furthermore, the inference engine can quickly provide guidance in the areas listed below in Table 4.
  • a medical history user interface 50 for entering data about a patient's medical history according to the present invention is illustrated.
  • the medical history user interface 50 can be displayed by activating the "Medical History" tab 50a.
  • the illustrated medical history user interface 50 allows a user to create, save, update and print patient records.
  • the medical history user interface 50 appears with empty data entry fields.
  • Data entry fields for receiving information via a GUI are well known to those of skill in the art and need not be described further herein.
  • the medical history user interface 50 appears with patient data in the various fields. Preferably color is used to highlight critical or required information in a patient record.
  • Important elements in the illustrated medical history user interface 50 include a "print” button 51 for printing a patient record and therapeutic treatment regimen details; a “save” button 52 for saving a patient record; and a "speed entry” check box 53 for allowing a user to move quickly between entry fields.
  • group headings 54 that divide a patient's medical history into related categories. Each group contains entry fields in which a user can add patient information.
  • An “add” button 55 allows a user to add new information to a patient record for a selected group.
  • a “delete” button 56 allows a user to delete patient information for a selected group (although the original information is still recorded in the database) .
  • a “history” button 57 allows a user to review a patient's historical data for each selected group.
  • an inference engine analyzes the data and suggests whether a therapeutic treatment regimen is indicated; if an existing therapeutic treatment regimen should be continued or changed; and the best drug therapies for the selected patient. Often, more than one drug therapy is presented to the user. These drug therapies are preferably ranked according to expected efficacy, frequency in dosage, pill count, and cost. All of these factors can help the user make a decision about what therapy to use for the selected patient.
  • a user clicks on a drug therapy in the presented list information is provided about the dosage regimens. Also, various warnings, such as drug interaction warnings, and notes about each drug, are presented. An appropriate drug therapy can then be selected.
  • FIG. 5 an exemplary user interface chart 60 for monitoring a patient's condition during a particular drug therapy over a period of time is illustrated.
  • the user interface chart 60 can be displayed by activating the "Chart" tab 60a.
  • the illustrated user interface chart 60 tracks the CD4 level against viral load. Along the left-hand side of the Y-axis 61 the CD4 count is plotted. Along the right-hand side of the Y-axis 61 the viral load count is plotted.
  • the lines 62 represent the CD4 test and the viral load test as would be understood by those having skill in the art.
  • Drug therapy for a time period is indicated within the area of the chart user interface 60 indicated as 63. Time is plotted along the X-axis 64, as illustrated.
  • a therapy evaluation user interface 70 that facilitates evaluation of various therapy options with respect to relative efficacy, dosage, frequency, cost, medical complications and drug interactions is illustrated.
  • the therapy evaluation user interface 70 can be displayed by activating the
  • "Therapy Evaluation” tab 70a Important elements in the illustrated therapy evaluation user interface 70 include an "Evaluate Current Therapy” button 71 for initiating an evaluation of a current therapy and a "Current Therapy” field 72 that lists a patient's current therapy. Detailed information about a patient's therapy is displayed in the therapy details box 73. A therapy displayed within box 73 is identified in box 74. Multiple check boxes 75 are provided that allow a user to control how information is displayed within the therapy evaluation user interface 70. Within the therapy list box 76, a list of available therapies for a patient can be displayed. In the illustrated embodiment the drugs are listed in standard abbreviated form. Other information displayed with each drug may include that listed below in Table 5.
  • a list of available antiretroviral drugs is displayed within box 77.
  • a user desiring to evaluate a particular combination of drugs can click the appropriate check boxes 77a to review information in the therapy details box 73.
  • a "Use as Current Therapy" button 78 allows a user to apply a particular therapy to a patient.
  • Various hyperlinks 79 within the therapy details box 73 allow a user to display specific information about a therapy evaluation. For example, a user can be allowed to view a rule which is associated with the displayed text .
  • Resistance evaluation alerts 80 can be provided adjacent each available antiretroviral drug displayed within box 77.
  • a blue "G” icon can be used to indicate that a patient's last genotype test contains mutations which are known to be associated with full or partial resistance to the antiretroviral drug.
  • a red “P” icon can be used to indicate that a patient's last phenotype test demonstrates resistance to the antiretroviral drug.
  • various symbols can be utilized to provide information about a drug therapy option. These symbols provide an instant graphical warning level for each therapy option. Some symbols, such as a red exclamation point, indicate that there is critical, possibly life threatening information in the therapy details box 73 for that therapy which must be read in order for that therapy to be properly utilized.
  • the therapy details box 73 of Fig. 6 can be displayed in "full screen” mode as illustrated in Fig. 8.
  • Important elements in the illustrated therapy details box 73 include an identification box 73a for identifying the therapy being evaluated; a "Use as Current Therapy” button 78 that allows a user to apply a particular therapy to a patient; and a "Show Therapies” button 73b that returns the therapy details box 73 back to half- screen size as illustrated in Fig. 6.
  • various hyperlinks may be embedded within text displayed within the therapy details box 73 that can be activated by a user to display various types of information.
  • Eye catching alert banner (s) 73c and text 73d can be displayed at the top of the therapy details box 73 as illustrated.
  • Dosages 73e of each drug, along with special administration instructions, can be displayed within the therapy details box 73 as illustrated.
  • Dosage adjustment information 73f and various warnings and advisories 73g can also be displayed within the therapy details box 73 as illustrated.
  • therapeutic treatment regimens are not displayed to a user if an invalid drug is selected for treatment of a patient .
  • Physicians Desk Reference® According to a preferred embodiment of the present invention, the Physicians Desk Reference®
  • PDR® 28 which is a known drug reference source, is fully integrated with the system 20 of Fig. 2. Users can access the PDR® drug abstracts for antiretroviral drugs listed in the therapy list box 76 of the therapy evaluation user interface 70 of Fig. 6. In addition, users can access the PDR® on-line Web database to obtain additional information about a specific drug or to research a substitute for a contraindicated drug.
  • a web browser preferably is launched and the PDR® on-line Web database is accessed. Information can also be extracted from the PDR® on-line Web database to provide drug selection lists for non-antiretroviral drugs that a patient may be taking and to define relationships between brand name and generic drugs .
  • a PDR® pop-up menu 90 may be provided that can be activated from within the therapy list box 76 of the therapy evaluation user interface 70 of Fig. 6. From the PDR® pop-up menu 90 a user can access various information from the PDR® including, but not limited to, drug abstracts, and generic components contained within a brand name drug.
  • the following non-limiting examples illustrate various aspects of the present invention. These examples are provided for illustrative purposes only, and are not intended to be limiting of the invention.
  • Figs. 10A-10D a medical history user interface 50 containing evaluated data for patient "demol" is illustrated.
  • the group heading "Hemoglobin” 54a has changed colors to indicate to a user that the patient has an abnormally low hemoglobin value from a previous (historical) blood sampling.
  • the therapy evaluation tab 70a is activated to display the therapy evaluation user interface 70 (Fig. 10B) the associated medical condition warning of a history of anemia and the caution notification if using drugs known to be associated with hematopoetic toxicity is triggered as illustrated in the therapy details box 73 of Fig. 10B.
  • Fig. IOC the "Chart" user interface 60 has been activated. HIV RNA (viral load) is plotted on a log scale, the CD4 count is plotted on a linear scale, and the drug treatments are shown as Gantt bars on the horizontal date scale at the bottom of the chart user interface 60.
  • HIV RNA viral load
  • CD4 count is plotted on a linear scale
  • drug treatments are shown as Gantt bars on the horizontal date scale at the bottom of the chart user interface 60.
  • This box represents the processing of the data from the "Medical History” tab and the knowledge base output, including objective rules derived from published treatment guidelines, indicating that initiation of therapy, or a change of therapy in this case, may be called for if the other variable (s) indicated in the message have been addressed.
  • the list of available therapies and associated ranking order may be shown within the therapy details box 73 of Fig. 10B. This represents the output of the knowledge base for therapy selection. Included with the list of therapies can be any of the following: safety advisories (dosage adjustment, drug interaction, etc.) with a yellow triangle or red exclamation warning symbols; number of pills; daily cost of all three drugs; dosing regimen (q 8h, q 12 h, etc.) ; and dosages for all drugs in a regimen (including dosage adjustments if necessary) and pertinent information specific to the patient is listed in the dialog box.
  • safety advisories dosage adjustment, drug interaction, etc.
  • dosing regimen q 8h, q 12 h, etc.
  • dosages for all drugs in a regimen including dosage adjustments if necessary
  • Example 2 will be explained with reference to Figs. 11A-11E, and relates to patient file "ARV naivel" which is an example of an HIV- infected patient who has not been treated with anti-HIV drugs previously.
  • Fig. 11A a medical history user interface 50 containing evaluated data for patient "ARV naivel” is illustrated.
  • Fig. 11B when the "Therapy Evaluation" tab 70a is activated to display the therapy evaluation user interface 70, a "Boundary and Prequalification Messages" message box MB2 pops up indicating that according to the current, published, HIV treatment guidelines, the patient should be initiated on antiviral therapy and that the current guidelines recommend combinational therapy.
  • the therapy evaluation user interface 70 has been activated and demonstrates features/functions associated with therapy evaluation including a general warning Wl and advisories Al, A2, and A3 for the patient related to treatment of the disease ( e . g . , whether therapy should be initiated or changed) or related to a specific therapy selected from the list box which is being evaluated by the user.
  • Fig. 11D illustrates various information that is displayable by clicking on an individual therapy in the therapy list box 76 of Fig. 11C. Information displayed includes dosages of all drugs with general and patient-specific warnings and advisories.
  • FIG. 11C are illustrated in Fig. HE and include: linking to an electronic PDR® to show drug package insert information or perform drug search information; showing or hiding columns of information displayed within the therapy list box; linking to a publication or abstract associated with a therapy that has a "book” icon associated therewith; and various printing functions.
  • Figs. 12A-12C and relates to patient file "Featuresl" which illustrates some important functions/features that a system according to the present invention can provide for highly drug experienced patients who may have developed resistance associated with the use of several antiviral drugs.
  • Features, including functions attributed to the new resistance and historical therapy rules are illustrated and includes:
  • Warning W3 is for the interaction between Nevirapine and rifabutin (which was selected from the list of non-antiretroviral drugs available as part of the medical history user interface 50) .
  • the drug interaction warning message may be viewed from the medical history user interface 50 by "right- clicking" the non-ARV title bar 54C, which has turned yellow indicating the presence of an ARV-nonARV drug interaction. This information is also prominently displayed for the user on the therapy evaluation user interface 70 as a text message ( 3 , Fig. 12B) as well as in the "Safety Considerations" section of the drug list box (76, Fig. 12B) ; and
  • the chart user interface 60 (Fig. 12A) illustrates the viral load, CD4 , drug therapies, and associated drug resistance in graphic form for the user to evaluate .

Abstract

Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen for a known disease such as HIV infection are disclosed. The method comprises (a) providing patient information to a computing device (11) (the computer device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for the disease (11); a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for the disease (11); and a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of the different therapeutic treatment regimens (11); and (b) generating in the computing device a listing (preferably a ranked listing) of therapeutic treatment regimens for the patient (12); and (c) generating in the computing device advisory information (13) for one or more treatment regimens in the listing based on the patient information and the expert rules.

Description

SYSTEMS, METHODS AND COMPUTER PROGRAM PRODUCTS FOR GUIDING THE SELECTION OF THERAPEUTIC TREATMENT REGIMENS
A portion of the disclosure of this patent document contains material that is the subject of copyright protection. The copyright owner does not object to the reproduction of the patent disclosure as it appears in the public patent files of the United States Patent and Trademark Office, but otherwise reserves all other rights in the copyrighted material.
Related Applications This application claims the benefit of U.S.
Provisional Application No. 60/080,629 filed April 3, 1998.
Field of the Invention This invention concerns systems, methods and computer program products for guiding the selection of therapeutic treatment regimens for complex disorders such as cancer and HIV-1 infection, wherein a ranking of available treatment regimens is generated and advisory information clinically useful for treating patients is provided. Background of the Invention
Therapeutic treatment regimens for disorders such as HIV-1 infection (acquired immune deficiency syndrome or AIDS) and cancer are increasingly complex. New data and new therapeutic treatment regimens continue to modify the treatments available, and it is difficult for all but the specialist to remain current on the latest treatment information. Further, even those who are current on the latest treatment information require time to assimilate that information and understand how it relates to other treatment information in order to provide the best available treatment for a patient. Combination therapeutic treatment regimens exacerbate this problem by making potential drug interactions even more complex. Finally, an increasingly sophisticated patient population, in the face of a vast volume of consumer information on the treatment of disease, makes the mere statement of a treatment regime, without explanation, difficult for the patient to accept.
R. Miller et al . , Summary Recommendations for Responsible Moni toring and Regulation of Clinical Software Systems, Ann. Intern. Med. 127, 842-845 (1997) , describes policy guidelines indicating the desirability of systems that generate advice for clinician users in a manner that users can easily override. Solutions to this need are neither suggested nor disclosed.
M. Pazzani et al . , Application of an Expert System in the Management of HIV- Infected Patients, J. Acquired Immune Deficiency Syndromes and Human Retrovirology 15, 356-362 (1997) (accepted May 12, 1997) , describes a rule-based expert system by which protease, reverse transcriptase, and integrase segments of HIV are cloned and entered into an expert system that recommends two, three, and four drug regimens. A means for easily overriding the advice given is neither suggested nor disclosed.
U.S. Patent No. 5,672,154 to Sillen describes a method for giving patients individualized, situation- dependent medication advice. The recommended type of medicine may include at least two different medicines. No means for ranking multiple treatment options is disclosed, and no means for explaining why treatment options were rejected is given. Rather, this system is primarily concerned with generating new rules from patient information to optimize a particular therapy for diseases such as Parkinson's disease, epilepsy and abnormal blood pressure .
U.S. Patent No. 5,694,950 to McMichael describes a method and system for use in treating a patient with immunosuppressants such as cyclosporin. An expert system is employed to generate a recommendation on whether the immunosuppressant dosage should be changed and, if so, how. Ranking or selection among a plurality of different combination therapeutic treatment regimens is not suggested.
U.S. Patent No. 5,594,638 to Iliff describes a medical diagnostic system that provides medical advice to the general public over a telephone network. This system is not concerned with generating a recommendation for a combination therapeutic treatment regimen for a known disease (see also U.S. Patent No. 5,660,176 to Iliff) .
Summary of the Invention In view of the foregoing, an object of the invention is to provide systems, methods and computer program products for selecting therapeutic treatment regimens for patients in which available treatments are listed, and optionally ranked, while unavailable or rejected treatment regimens (e.g., regimens that would not be effective, or would be dangerous) are not displayed or are assigned a low rank and are indicated to a user as not likely to be efficacious, or not preferred due to patient-specific complicating factors such as drug interaction from concomitant medications.
A further object of the invention is to provide systems, methods and computer program products for selecting treatment regimens in which the available treatment options can be readily understood. A further object of the invention is to provide systems, methods and computer program products for selecting treatment regimens in which the implications of selecting a particular treatment regimen can be readily understood. A further object of the invention is to provide systems, methods and computer program products for selecting treatment regimens in which the reasons for rejection of a particular regimen can be readily understood. A still further object of the invention is to provide systems, methods and computer program products for obtaining information about the efficacy of previous treatment regimens imposed on patients.
A method of the present invention includes providing patient information to a computing device that includes various knowledge bases. For example, a first knowledge base may include a plurality of different therapeutic treatment regimens for a disease or medical condition. A second knowledge base may include a plurality of expert rules for selecting a therapeutic treatment regimen for the disease or medical condition. A third knowledge base may include advisory information useful for the treatment of a patient with different constituents of different therapeutic treatment regimens. A fourth knowledge base may include information about past therapies, such as how a patient has fared under previous therapies.
A listing (preferably a ranked listing) of therapeutic treatment regimens for a patient is generated in the computing device. Advisory information for one or more treatment regimens in the listing is generated in the computing device based on the patient information and the expert rules .
In a preferred embodiment, the method described above further includes entering a user- defined therapeutic treatment regimen for the disease (or medical condition) that may not be displayed from the system knowledge base-generated therapeutic treatment regimens, and generating in the computing device advisory information for the user-defined combination therapeutic treatment regimen.
In addition, in a preferred embodiment, the method described above further includes entering a rejected therapeutic treatment regimen for the disease (or medical condition) that is included in the first knowledge base but not recommended from the ranking (or given a very low ranking) , and generating in the computing device advisory information for the non- recommended/low ranked therapeutic treatment regimen, wherein the advisory information includes at least one reason for not recommending (or low ranking) the therapeutic treatment regimen.
Further objects and aspects of the present invention are explained in detail in the drawings herein and the specification set forth below.
Brief Description of the Drawings
The accompanying drawings , which are incorporated in and constitute a part of the specification, illustrate embodiments of the invention and, together with the description, serve to explain principles of the invention.
Fig. 1 illustrates a process of the instant invention, including routines for entering a user- defined therapeutic treatment regimen and for entering a "non-recommended" therapeutic treatment regimen. Fig. 2 schematically illustrates a system or apparatus of the present invention.
Fig. 3 illustrates a client-server environment within which the system of Fig. 2 may operate, according to an embodiment of the present invention, and wherein a central server is accessible by at least one local server via a computer network, such as the Internet, and wherein each local server is accessible by at least one client.
Fig. 4 illustrates a medical history user interface for entering data about a patient ' s medical history according to the present invention.
Fig. 5 illustrate a user interface chart for monitoring a patient's condition during a particular therapeutic treatment regimen over a period of time according to the present invention. Fig. 6 illustrates a therapy evaluation user interface that facilitates evaluation of various therapeutic treatment regimen options with respect to relative efficacy, individualized adjusted relative efficacy, dosage, frequency, cost, medical complications and drug interactions according to the present invention.
Fig. 7 illustrates various symbols for providing information about a therapeutic treatment regimen option within the therapy list box of the therapy evaluation user interface of Fig. 6 according to the present invention.
Fig. 8 illustrates the therapy details box of Fig. 6 in "full screen" mode.
Fig. 9 illustrates a pop-up menu including an indexed electronic link to a PDR® that can be activated from within the therapy list box of the therapy evaluation user interface of Fig. 6 according to the present invention.
Figs. 10A-10D illustrate various functions of the present invention as described in Example 1.
Figs. 11A-11E illustrate various functions of the present invention as described in Example 2.
Figs. 12A-12C illustrate various functions of the present invention as described in Example 3.
Detailed Description of the Invention
The present invention now will be described more fully hereinafter with reference to the accompanying drawings, in which preferred embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. Like numbers refer to like elements throughout .
As will be appreciated by one of skill in the art, the present invention may be embodied as a method, data processing system, or computer program product. Accordingly, the present invention may take the form of an entirely hardware embodiment, an entirely software embodiment, or an embodiment combining software and hardware aspects. Furthermore, the present invention may take the form of a computer program product on a computer-usable storage medium having computer readable program code means embodied in the medium. Any suitable computer readable medium may be utilized including, but not limited to, hard disks, CD-ROMs, optical storage devices, and magnetic storage devices. The present invention is described below with reference to flowchart illustrations of methods, apparatus (systems) , and computer program products according to an embodiment of the invention. It will be understood that each block of the flowchart illustrations, and combinations of blocks in the flowchart illustrations, can be implemented by computer program instructions. These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer or other programmable data processing apparatus, create means for implementing the functions specified in the flowchart block or blocks . These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means which implement the function specified in the flowchart block or blocks.
The computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the functions specified in the flowchart block or blocks. A method of the instant invention is illustrated in Fig. 1. In the first step 10, the patient is examined to determine patient information. Examples of patient information that may be gathered include one or more of gender, age, weight, CD4+ cell information, viral load information, HIV genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information, and information for drug treatments for other conditions. The information may include historical information on prior therapeutic treatment regimens for the disease or medical condition. While the patient is typically examined on a first visit to determine the patient information, it will be appreciated that patient information may also be stored in the computing device, or transferred to the computing device from another computing device, storage device, or hard copy, when the information has been previously determined.
The patient information is then provided 11 to a computing device that contains a knowledge base of treatments, contains a knowledge base of expert rules for determining available treatment options for the patient in light of the patient information, and also contains a knowledge base of advisory information. A list of available treatments for the patient is then generated 12 from the patient information and the available treatments by the expert rules, and advisory information for the available treatments is generated 13. The advisory information may include warnings to take the patient off a contraindicated drug or select a suitable non contraindicated drug to treat the condition before initiating a corresponding treatment regimen and/or information clinically useful to implement a corresponding therapeutic treatment regimen .
For example, when the known disease is HIV-1 infection, the treatment regimen includes antiretroviral drugs, and the treatment regimen or advisory information may also include contraindicated or potentially adversely interacting non-antiretroviral drugs. Particularly, when the treatment regimen includes a protease inhibitor. A contraindicated drug may be terfenadine. When the treatment regimen includes indinavir, a contraindicated drug is cisapride.
Exemplary antiretroviral drugs are listed below in Table 1.
Table 1
Figure imgf000013_0001
Exemplary advisory information that can be displayed to a user is summarized below in Table 2 .
Table 2
Figure imgf000014_0001
Figure imgf000015_0001
Diseases (or medical conditions) , the treatment of which may be facilitated or improved by the present invention, are those for which multiple different therapy options are available for selection and treatment. Such diseases and medical conditions include, but are not limited to, cardiovascular disease (including but not limited to congestive heart failure, hypertension, hyperlipidemia and angina) , pulmonary disease (including but not limited to chronic obstructive pulmonary disease, asthma, pneumonia, cystic fibrosis, and tuberculosis) , neurologic disease (including but not limited to Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, amyotrophic lateral sclerosis or ALS, psychoses such as schizophrenia and organic brain syndrome, neuroses, including anxiety, depression and bipolar disorder) , hepatitis infections (including hepatitis B and hepatitis C infection) , urinary tract infections, venereal disease, cancer (including but not limited to breast, lung, prostate, and colon cancer), etc. It should be appreciated that prevention of development or onset of the above-mentioned diseases and medical conditions may be facilitated or improved by the present invention. The present invention is useful for known diseases such as HIV-1 infection (acquired immune deficiency syndrome or "AIDS"), or where the known disease is any medical condition for which a combination therapeutic treatment regimen can be used. The invention is particularly useful when the list of available treatments includes a plurality (e.g., 2, 10 or 15 or more) of treatment, combination therapeutic treatment regimens { e. g. , therapeutic treatment regimens incorporating two or more active therapeutic agents) , where the potential for drug interactions is increased and/or the complexity involved in selecting the best available treatment is multifactorial . Advantageously, the list of available treatments and advisory information may be regenerated in a number of ways. The patient information may be simply modified 18. In addition, if a particular therapy in which the user might be interested is not presented, a user-defined therapy may be entered 14 and advisory information generated 15 based on the user- defined therapy. Still further, if a therapeutic treatment regimen that is in the knowledge base is rejected by the system (not recommended upon display) , the non-recommended therapeutic treatment regimen may be entered 16 and advisory information generated 17 for the non-recommended therapeutic treatment regimen. This may indicate to the user that they should discontinue use of a non-critical drug for another condition or select a suitable substitute that does not create a conflict/non-recommended situation so that they can then proceed with the therapy of choice. Alternatively, the advisory information can be generated automatically for non-recommended therapeutic treatment regimens. These various steps can be repeated in any sequence in an interactive manner to provide the user with assurance that all treatment options have been given adequate and appropriate consideration.
The terms "therapy" and "therapeutic treatment regimen" are interchangeable herein and, as used herein, mean any pharmaceutical or drug therapy, regardless of the route of delivery (e.g., oral, intraveneous, intramuscular, subcutaneous, intraarterial, intraperitoneal, intrathecal, etc.), for any disease (including both chronic and acute medical conditions, disorders, and the like) . In addition, it is understood that the present invention is not limited to facilitating or improving the treatment of diseases. The present invention may be utilized to facilitate or improve the treatment of patients having various medical conditions, without limitation.
System Description The present invention may be embodied as an expert system that provides decision support to physicians (or other health care providers) treating patients with a known disease, such as HIV infection. A system according to the present invention calculates combination antiretroviral therapy options and attaches all relevant information to those options.
As known to those of skill in the art, an expert system, also known as artificial intelligence (Al) , is a computer program that can simulate the judgment and behavior of a human or an organization that has expert knowledge and experience in a particular field. An expert system typically contains a knowledge base containing accumulated experience and a set of rules for applying the knowledge base to each particular situation that is described to the program. Expert systems are well known to those of skill in the art and need not be described further herein. The antiretroviral therapy options (combinations of antiretroviral drugs) , are derived using a knowledge base consisting of a number of expert system rules and functions which in turn take into account a given patient's treatment history, current condition and laboratory values. A system according to the present invention supports the entry, storage, and analysis of patient data in a large central database. A system according to the present invention has a flexible data driven architecture and custom reporting capabilities designed to support patient therapy management and clinical drug trial activities such as screening, patient tracking and support. It is anticipated that a system according to the present invention may be used by health care providers (including physicians) , clinical research scientists, and possibly healthcare organizations seeking to find the most cost-effective treatment options for patients while providing the highest standard of care.
A system 20 for carrying out the present invention is schematically illustrated in Fig. 2. The system 20 comprises a knowledge base of treatment regimens 21, which may be ranked for efficacy ( e . g. , by a panel of experts) or ranked according to system rules, a knowledge base of expert rules 22, a knowledge base of advisory information 23, a knowledge base of patient therapy history 24 and patient information 25. Patient information is preferably stored within a database and is configured to be updated. The knowledge bases and patient information 21-25 may be updated by an input/output system 29, which can comprise a keyboard (and/or mouse) and video monitor. Note also that, while the knowledge bases and patient data 21-25 are shown as separate blocks, the knowledge bases and patient data 21-25 can be combined together ( e . g. , the expert rules and the advisory information can be combined in a single database) . To carry out the method described above, the information from blocks 21-25 is provided to an inference engine 26, which generates the listing of available treatments and the corresponding advisory information from the information provided by blocks 21- 25. The inference engine 26 may be implemented as hardware, software, or combinations thereof. Inference engines are known and any of a variety thereof may be used to carry out the present invention. Examples include, but are not limited to, those described in U.S. Patents Nos. 5,263,127 to Barabash et al . (Method for fast rule execution of expert systems); 5,720,009 to Kirk et al . (Method of rule execution in an expert system using equivalence classes to group database objects); 5,642,471 to Paillet (Production rule filter mechanism and inference engine for expert system) ;
5,664,062 to Kim (High performance max-min circuit for a fuzzy inference engine) .
High-speed inference engines are preferred so that the results of data entered are continually updated as new data is entered. As with the knowledge bases and patient information in blocks 21-25, the inference engine 26 may be a separate block from the knowledge bases and patient information blocks 21-25, or may be combined together in a common program or routine. Note that the advisory information that is generated for any available therapy may differ from instance to instance based on differences in the patient information provided.
System Architecture
The present invention can be implemented as a system running on a stand alone computing device . Preferably, the present invention is implemented as a system in a client-server environment. As is known to those of skill in the art, a client application is the requesting program in a client-server relationship. A server application is a program that awaits and fulfills requests from client programs in the same or other computers. Client-server environments may include public networks, such as the Internet, and private networks often referred to as "intranets", local area networks (LANs) and wide area networks (WANs) , virtual private networks (VPNs) , frame relay or direct telephone connections. It is understood that a client application or server application, including computers hosting client and server applications, or other apparatus configured to execute program code embodied within computer usable media, operates as means for performing the various functions and carries out the methods of the various operations of the present invention.
Referring now to Fig. 3, a client-server environment 30 according to a preferred embodiment of the present invention is illustrated. The illustrated client-server environment 30 includes a central server 32 that is accessible by at least one local server 34 via a computer network 36, such as the Internet. A variety of computer network transport protocols including, but not limited to TCP/IP, can be utilized for communicating between the central server 32 and the local servers 34.
Central Server The central server 32 includes a central database 38, such as the Microsoft® SQL Server application program, version 6.5 (available from
Microsoft, Inc., Redmond, WA) , executing thereon. The central server 32 ensures that the local servers 34 are running the most recent version of a knowledge base. The central server 32 also stores all patient data and performs various administrative functions including adding and deleting local servers and users to the system (20, Fig. 2) . The central server 32 also provides authorization before a local server 34 can be utilized by a user. Patient data is preferably stored on the central server 32, thereby providing a central repository of patient data. However, it is understood that patient data can be stored on a local server 34 or on local storage media.
Local Server Each local server 34 typically serves multiple users in a geographical location. Each local server 34 includes a server application, an inference engine, one or more knowledge bases, and a local database 39. Each local server 34 performs artificial intelligence processing for carrying out operations of the present invention. When a user logs on to a local server 34 via a client 35, the user is preferably authenticated via an identification and password, as would be understood by those skilled in the art. Once authenticated, a user is permitted access to the system (20, Fig. 2) and certain administrative privileges are assigned to the user.
Each local server 34 also communicates with the central server 32 to verify that the most up-to- date version of the knowledge base(s) and application are running on the requesting local server 34. If not, the requesting local server 34 downloads from the central server 32 the latest validated knowledge base(s) and/or application before a user session is established. Once a user has logged onto the system (20, Fig. 2) and has established a user session, all data and artificial intelligence processing is preferably performed on a local server 34. An advantage of the illustrated client-server configuration is that most of the computationally intensive work occurs on a local server 34, thereby allowing "thin" clients 35 (i.e., computing devices having minimal hardware) and optimizing system speed.
In a preferred embodiment, each local server database 39 is implemented via a Microsoft® SQL Server application program, Version 6.5. The primary purpose of each local database 39 is to store various patient identifiers and to ensure secure and authorized access to the system (20, Fig. 2) by a user. It is to be understood, however, that both central and local databases 38, 39 may be hosted on the central server 32.
Local Client Each local client 35 also includes a client application program that consists of a graphical user interface (GUI) and a middle layer program that communicates with a local server 34. Program code for the client application program may execute entirely on a local client 35, or it may execute partly on a local client 35 and partly on a local server 34. As will be described below, a user interacts with the system (20, Fig. 2) by entering (or accessing) patient data within a GUI displayed within the client 35. The client 35 then communicates with a local server 34 for analysis of the displayed patient information.
Computer program code for carrying out operations of the present invention is preferably written in an object oriented programming language such as JAVA®, Smalltalk, or C++. However, the computer program code for carrying out operations of the present invention may also be written in conventional procedural programming languages, such as the "C" programming language, in an interpreted scripting language, such as Perl, or in a functional (or fourth generation) programming language such as Lisp, SML, or Forth.
The middle layer program of the client application includes an inference engine within a local server 34 that provides continuous on-line direction to users, and can instantly warn a user when a patient is assigned drugs or a medical condition that is contraindicated with, or antagonistic of, the patient's current antiretroviral therapy. Every time patient data is entered into the system (20, Fig. 2) or updated, or even as time passes, the inference engine evaluates the current status of the patient data, sorting, categorizing, ranking and customizing every possible antiretroviral therapy for a patient according to the specific needs of the patient.
Inference Engine
Inference engines are well known by those of skill in the art and need not be described further herein. Each knowledge base used by an inference engine according to the present invention is a collection of rules and methods authored by a clinical advisory panel of HIV-treating physicians and scientists. A knowledge base may have subjective rules, objective rules, and system-generated rules. Objective rules are based on industry established facts regarding the treatment of HIV using antiretroviral therapy and are drawn from the package insert information of antiretroviral drug manufacturers and from peer reviewed and published journal articles. An example of an objective rule would be an antiretroviral to antiretroviral contraindication such as :
Rule #1: If the eval therapy contains Zidovudine (AZT) and Stavudine (d4T) , then reject the therapy.
In Rule #1, the term "eval therapy" refers to the therapy currently being analyzed by the system (20, Fig. 2) . Rule #1 then states that if this therapy contains both AZT and d4T, then this therapy should not be displayed in a list of potential therapy options for the patient.
For objective rules, the present invention can be configured so as to prevent a user from receiving recommendations on new therapy options when certain crucial data on the patient has not been entered. However, it is understood that the present invention does not prevent a health care provider, such as a physician, from recording his/her therapy decisions, even if the system (20, Fig. 2) has shown reasons why that therapy may be harmful to the patient. The present invention allows a health care provider to be the final authority regarding patient therapy.
Subjective rules are based on expert opinions, observations and experience. Subjective rules are typically developed from "best practices" information based on consensus opinion of experts in the field. Such expert opinion may be based on knowledge of the literature published or presented in the field or their own experience from clinical practice, research or clinical trials of approved and unapproved medications. A number of experts are used so that personal bias is reduced. System generated rules are those derived from the outcomes of patients tracked in the system who received known and defined therapies and either improved, stabilized or worsened during a defined period. Because of the large number of potential combinations usable in HIV infection, this system generated database and rules derived from them are likely to encompass data beyond that achievable from objective or subjective rules databases.
The rules which comprise the various knowledge bases (21-24, Fig. 2) of the present invention each have two main parts : a premise and a conclusion - also referred to as the left side and the right side, respectively. When a premise of a rule is found to be true, the action specified in the conclusion is taken. This is known to those of skill in the art as "firing" the rule. For example, consider the following rule:
Rule ID Premise Conclusion FiltDComAl -- If the eval therapy contains ddC - Commentary 18
The premise of the above rule is for the inference engine to determine whether or not a therapy being evaluated (i.e., "eval therapy") contains the antiretroviral drug "ddC" . If a therapy does contain the antiretroviral drug ddC, the action called for by the conclusion of the rule is to attach "Commentary 18" to the therapy. Commentary 18 may be a piece of text that provides a user with the necessary information about therapies containing ddC.
Exemplary rules which may comprise one or more knowledge bases according to the present invention are listed below in Table 3.
Table 3
Therapy initiation/change: Rules that provide information on therapy change or initiation
Boundary condition rules: Limits for values, intervals for values to be updated
Comment Data Aging rules: These rules warn the user that the data in certain fields is getting old and that the most current values in the system will be used.
Rules that filter therapies due to drug interactions in ARV drug combinations
Rules that filter therapies due to medical conditions
Rules that filter therapies due to genotypic mutations in patient's plasma HIV
Rules that filter therapies due to phenotypic sensitivity/resistance
Antiretroviral therapy ranking rules
General dosage rules
Solid dosage rule
Dosage modifications due to ARV-ARV drug combination
Dosage modification due to ARV-NonARV interaction
Dosage modification due to medical condition
Comment determined
General commentary rules
Commentaries added due to medical conditions
Commentaries added due to drug interactions Commentaries added due to drug combination
Delivery size rules
Using the various knowledge bases and patient information of the present invention (21-25, Fig. 2) , the inference engine (26, Fig. 2) can evaluate potential therapy options for a patient based on a patient's medical history (including therapy history) and current laboratory values. Accordingly multiple antiretroviral drug combinations can be quickly and accurately analyzed for a particular patient. Furthermore, the inference engine can quickly provide guidance in the areas listed below in Table 4.
Table 4
Figure imgf000028_0001
Figure imgf000029_0001
User Interface Referring now to Figs. 4-9, exemplary user interfaces according to the present invention will be illustrated. In Fig. 4, a medical history user interface 50 for entering data about a patient's medical history according to the present invention is illustrated. The medical history user interface 50 can be displayed by activating the "Medical History" tab 50a. The illustrated medical history user interface 50 allows a user to create, save, update and print patient records. When a user adds a new patient, the medical history user interface 50 appears with empty data entry fields. Data entry fields for receiving information via a GUI are well known to those of skill in the art and need not be described further herein. When a user opens a patient record for editing, the medical history user interface 50 appears with patient data in the various fields. Preferably color is used to highlight critical or required information in a patient record.
Important elements in the illustrated medical history user interface 50 include a "print" button 51 for printing a patient record and therapeutic treatment regimen details; a "save" button 52 for saving a patient record; and a "speed entry" check box 53 for allowing a user to move quickly between entry fields. In addition, there are multiple group headings 54 that divide a patient's medical history into related categories. Each group contains entry fields in which a user can add patient information. An "add" button 55 allows a user to add new information to a patient record for a selected group. A "delete" button 56 allows a user to delete patient information for a selected group (although the original information is still recorded in the database) . A "history" button 57 allows a user to review a patient's historical data for each selected group.
After completing a patient's medical history, an inference engine analyzes the data and suggests whether a therapeutic treatment regimen is indicated; if an existing therapeutic treatment regimen should be continued or changed; and the best drug therapies for the selected patient. Often, more than one drug therapy is presented to the user. These drug therapies are preferably ranked according to expected efficacy, frequency in dosage, pill count, and cost. All of these factors can help the user make a decision about what therapy to use for the selected patient. When a user clicks on a drug therapy in the presented list, information is provided about the dosage regimens. Also, various warnings, such as drug interaction warnings, and notes about each drug, are presented. An appropriate drug therapy can then be selected.
In Fig. 5, an exemplary user interface chart 60 for monitoring a patient's condition during a particular drug therapy over a period of time is illustrated. The user interface chart 60 can be displayed by activating the "Chart" tab 60a. The illustrated user interface chart 60 tracks the CD4 level against viral load. Along the left-hand side of the Y-axis 61 the CD4 count is plotted. Along the right-hand side of the Y-axis 61 the viral load count is plotted. The lines 62 represent the CD4 test and the viral load test as would be understood by those having skill in the art. Drug therapy for a time period is indicated within the area of the chart user interface 60 indicated as 63. Time is plotted along the X-axis 64, as illustrated.
In Fig. 6, a therapy evaluation user interface 70 that facilitates evaluation of various therapy options with respect to relative efficacy, dosage, frequency, cost, medical complications and drug interactions is illustrated. The therapy evaluation user interface 70 can be displayed by activating the
"Therapy Evaluation" tab 70a. Important elements in the illustrated therapy evaluation user interface 70 include an "Evaluate Current Therapy" button 71 for initiating an evaluation of a current therapy and a "Current Therapy" field 72 that lists a patient's current therapy. Detailed information about a patient's therapy is displayed in the therapy details box 73. A therapy displayed within box 73 is identified in box 74. Multiple check boxes 75 are provided that allow a user to control how information is displayed within the therapy evaluation user interface 70. Within the therapy list box 76, a list of available therapies for a patient can be displayed. In the illustrated embodiment the drugs are listed in standard abbreviated form. Other information displayed with each drug may include that listed below in Table 5.
Table 5
Figure imgf000032_0001
Figure imgf000033_0001
A list of available antiretroviral drugs is displayed within box 77. A user desiring to evaluate a particular combination of drugs can click the appropriate check boxes 77a to review information in the therapy details box 73. A "Use as Current Therapy" button 78 allows a user to apply a particular therapy to a patient. Various hyperlinks 79 within the therapy details box 73 allow a user to display specific information about a therapy evaluation. For example, a user can be allowed to view a rule which is associated with the displayed text .
Resistance evaluation alerts 80 can be provided adjacent each available antiretroviral drug displayed within box 77. For example, a blue "G" icon can be used to indicate that a patient's last genotype test contains mutations which are known to be associated with full or partial resistance to the antiretroviral drug. A red "P" icon can be used to indicate that a patient's last phenotype test demonstrates resistance to the antiretroviral drug.
Within the therapy list box 76, various symbols (described in Fig. 7) can be utilized to provide information about a drug therapy option. These symbols provide an instant graphical warning level for each therapy option. Some symbols, such as a red exclamation point, indicate that there is critical, possibly life threatening information in the therapy details box 73 for that therapy which must be read in order for that therapy to be properly utilized.
When a drug therapy from the therapy list box 76 is selected by a user for evaluation, the therapy details box 73 of Fig. 6 can be displayed in "full screen" mode as illustrated in Fig. 8. Important elements in the illustrated therapy details box 73 include an identification box 73a for identifying the therapy being evaluated; a "Use as Current Therapy" button 78 that allows a user to apply a particular therapy to a patient; and a "Show Therapies" button 73b that returns the therapy details box 73 back to half- screen size as illustrated in Fig. 6. In addition, various hyperlinks may be embedded within text displayed within the therapy details box 73 that can be activated by a user to display various types of information. Eye catching alert banner (s) 73c and text 73d can be displayed at the top of the therapy details box 73 as illustrated. Dosages 73e of each drug, along with special administration instructions, can be displayed within the therapy details box 73 as illustrated. Dosage adjustment information 73f and various warnings and advisories 73g can also be displayed within the therapy details box 73 as illustrated.
According to a preferred embodiment of the present invention, therapeutic treatment regimens are not displayed to a user if an invalid drug is selected for treatment of a patient .
Physicians Desk Reference® According to a preferred embodiment of the present invention, the Physicians Desk Reference®
(PDR®) 28, which is a known drug reference source, is fully integrated with the system 20 of Fig. 2. Users can access the PDR® drug abstracts for antiretroviral drugs listed in the therapy list box 76 of the therapy evaluation user interface 70 of Fig. 6. In addition, users can access the PDR® on-line Web database to obtain additional information about a specific drug or to research a substitute for a contraindicated drug. When a user selects a drug within the therapy list box 76 of the therapy evaluation user interface 70, a web browser preferably is launched and the PDR® on-line Web database is accessed. Information can also be extracted from the PDR® on-line Web database to provide drug selection lists for non-antiretroviral drugs that a patient may be taking and to define relationships between brand name and generic drugs .
As illustrated in Fig. 9, a PDR® pop-up menu 90 may be provided that can be activated from within the therapy list box 76 of the therapy evaluation user interface 70 of Fig. 6. From the PDR® pop-up menu 90 a user can access various information from the PDR® including, but not limited to, drug abstracts, and generic components contained within a brand name drug. The following non-limiting examples illustrate various aspects of the present invention. These examples are provided for illustrative purposes only, and are not intended to be limiting of the invention.
EXAMPLE 1 Example 1 will be explained with reference to
Figs. 10A-10D. Referring to Fig. 10A, a medical history user interface 50 containing evaluated data for patient "demol" is illustrated. The group heading "Hemoglobin" 54a has changed colors to indicate to a user that the patient has an abnormally low hemoglobin value from a previous (historical) blood sampling. When the therapy evaluation tab 70a is activated to display the therapy evaluation user interface 70 (Fig. 10B) the associated medical condition warning of a history of anemia and the caution notification if using drugs known to be associated with hematopoetic toxicity is triggered as illustrated in the therapy details box 73 of Fig. 10B.
In addition, the group heading "Renal Function" 54b in Fig. 10A has changed colors to warn a user of potential renal dysfunction and is also indicated by the low estimated creatinine clearance rate in field FI (which the system calculates using a mathematical formula taking patient age, sex, weight-, and serum creatinine values - all of which are fields of the "Medical History" user interface 50) . This information is pointed out to the user and is used if dosage adjustments are required for drugs that are known to be affected (cleared) by renal function.
Current and the next most recent CD4+ cell count and viral load are displayed (F2, medical history user interface 50) . This information is also used to determine when to start or change therapy and to evaluate the initial antiviral efficacy of a newly administered antiviral regimen.
Current and historical values for all fields in the medical history user interface 50 (Fig. 10A) can be viewed by pressing the "H" button beside fields that have this button.
In Fig. IOC, the "Chart" user interface 60 has been activated. HIV RNA (viral load) is plotted on a log scale, the CD4 count is plotted on a linear scale, and the drug treatments are shown as Gantt bars on the horizontal date scale at the bottom of the chart user interface 60.
In Fig. 10D, the "Change Therapy Recommendation" message box MB1 pops up when the
"Therapy Evaluation" tab 70a is selected. This box represents the processing of the data from the "Medical History" tab and the knowledge base output, including objective rules derived from published treatment guidelines, indicating that initiation of therapy, or a change of therapy in this case, may be called for if the other variable (s) indicated in the message have been addressed.
The list of available therapies and associated ranking order may be shown within the therapy details box 73 of Fig. 10B. This represents the output of the knowledge base for therapy selection. Included with the list of therapies can be any of the following: safety advisories (dosage adjustment, drug interaction, etc.) with a yellow triangle or red exclamation warning symbols; number of pills; daily cost of all three drugs; dosing regimen (q 8h, q 12 h, etc.) ; and dosages for all drugs in a regimen (including dosage adjustments if necessary) and pertinent information specific to the patient is listed in the dialog box.
EXAMPLE 2
Example 2 will be explained with reference to Figs. 11A-11E, and relates to patient file "ARV naivel" which is an example of an HIV- infected patient who has not been treated with anti-HIV drugs previously. In Fig. 11A, a medical history user interface 50 containing evaluated data for patient "ARV naivel" is illustrated. In Fig. 11B, when the "Therapy Evaluation" tab 70a is activated to display the therapy evaluation user interface 70, a "Boundary and Prequalification Messages" message box MB2 pops up indicating that according to the current, published, HIV treatment guidelines, the patient should be initiated on antiviral therapy and that the current guidelines recommend combinational therapy.
In Fig. 11C, the therapy evaluation user interface 70 has been activated and demonstrates features/functions associated with therapy evaluation including a general warning Wl and advisories Al, A2, and A3 for the patient related to treatment of the disease ( e . g . , whether therapy should be initiated or changed) or related to a specific therapy selected from the list box which is being evaluated by the user. Fig. 11D illustrates various information that is displayable by clicking on an individual therapy in the therapy list box 76 of Fig. 11C. Information displayed includes dosages of all drugs with general and patient-specific warnings and advisories.
The features available by right clicking on any therapy listed in the therapy list box 76 of Fig.
11C are illustrated in Fig. HE and include: linking to an electronic PDR® to show drug package insert information or perform drug search information; showing or hiding columns of information displayed within the therapy list box; linking to a publication or abstract associated with a therapy that has a "book" icon associated therewith; and various printing functions.
EXAMPLE 3 Example 3 will be explained with reference to
Figs. 12A-12C, and relates to patient file "Featuresl" which illustrates some important functions/features that a system according to the present invention can provide for highly drug experienced patients who may have developed resistance associated with the use of several antiviral drugs. Features, including functions attributed to the new resistance and historical therapy rules are illustrated and includes:
1) Potential drug resistance advisories (Al, Fig. 12A) when the chart tab 60a is activated, or (A2 , Fig. 12B) when the therapy evaluation tab 70a is activated;
2) The heads up "P" and "G" indicators (II and 12, Fig. 12B) to remind of phenotypic or genotypic resistance associated with certain anti-HIV compounds as demonstrated for this patient (including indication of expected/anticipated genotypic resistance, as a result of cross-resistance, to a drug that a patient may not be taking currently or has not previously taken) ;
3) The drug interaction warning system (indicated by warning W3 , Fig. 12C) . Warning W3 is for the interaction between Nevirapine and rifabutin (which was selected from the list of non-antiretroviral drugs available as part of the medical history user interface 50) . The drug interaction warning message may be viewed from the medical history user interface 50 by "right- clicking" the non-ARV title bar 54C, which has turned yellow indicating the presence of an ARV-nonARV drug interaction. This information is also prominently displayed for the user on the therapy evaluation user interface 70 as a text message ( 3 , Fig. 12B) as well as in the "Safety Considerations" section of the drug list box (76, Fig. 12B) ; and
4) The chart user interface 60 (Fig. 12A) illustrates the viral load, CD4 , drug therapies, and associated drug resistance in graphic form for the user to evaluate . The foregoing is illustrative of the present invention and is not to be construed as limiting thereof. Although a few exemplary embodiments of this invention have been described, those skilled in the art will readily appreciate that many modifications are possible in the exemplary embodiments without materially departing from the novel teachings and advantages of this invention. Accordingly, all such modifications are intended to be included within the scope of this invention as defined in the claims. Therefore, it is to be understood that the foregoing is illustrative of the present invention and is not to be construed as limited to the specific embodiments disclosed, and that modifications to the disclosed embodiments, as well as other embodiments, are intended to be included within the scope of the appended claims . The invention is defined by the following claims, with equivalents of the claims to be included therein.

Claims

THAT WHICH IS CLAIMED IS:
1. A method for guiding the selection of a therapeutic treatment regimen for a patient with a known disease or medical condition, said method comprising: (a) providing patient information to a computing device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition; a second knowledge base comprising a plurality of expert rules for evaluating and selecting a therapeutic treatment regimen for said disease or medical condition; a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens ; and (b) generating in said computing device a listing of available therapeutic treatment regimens for said patient; and
(c) generating in said computing device advisory information for one or more therapeutic treatment regimens in said listing based on said patient information and said expert rules.
2. A method according to claim 1, further comprising the steps of:
(d) entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not included in said first knowledge base;
(e) generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
3. A method according to claim 1 , further comprising the steps of:
(f) entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and
(g) generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non- recommendation of said therapeutic treatment regimen.
4. A method according to claim 1, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information, and information for drug treatments for other conditions.
5. A method according to claim 1, said patient information including prior therapeutic treatment regimen information.
6. A method according to claim 1, wherein said listing of available therapeutic treatment regimens for said patient comprises a ranked listing of available therapeutic treatment regimens for said
> patient.
7. A method according to claim 1, wherein said patient information includes prior patient information stored in said computing device.
8. A method according to claim 1, said advisory information including: warnings to take the patient off a contraindicated drug before initiating a corresponding
> therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
9. A method according to claim 1, wherein said computing device comprises a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous j therapeutic treatment regimen information extracted from said fourth knowledge base .
10. A method according to claim 8, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment
5 regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
11. A method according to claim 8, wherein said therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine .
12. A method according to claim 8 , wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride.
13. A method according to claim 1, wherein said known disease or medical condition is one where multiple prophylactic or therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease.
14. A method according to claim 1, wherein said known disease or medical condition is a cardiovascular disease.
15. A method according to claim 1, wherein said known disease or medical condition is a pulmonary disease .
16. A method according to claim 1, wherein said known disease or medical condition is a neurologic disease .
17. A method according to claim 1, wherein said known disease or medical condition is cancer.
18. A method according to claim 1, wherein said known disease or medical condition is a urinary tract infection.
19. A method according to claim 1, wherein said known disease or medical condition is hepatitis.
20. A method according to claim 1, wherein said known disease or medical condition is HIV-1 infection.
21. A method according to claim 1, wherein said knowledge base comprises a plurality of different combination therapeutic treatment regimens.
22. A method according to claim 1, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
23. A method according to claim 1, further comprising the step of :
(d) accessing, via said computing device, information for one or more therapeutic treatment regimens from a drug reference source.
24. A system for guiding the selection of a therapeutic treatment regimen for a patient with a known disease or medical condition, said system comprising: i (a) a computing device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition; a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition; a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens ; and
(b) means for providing patient information to said computing device;
(c) means for generating in said computing device a listing of therapeutic treatment regimens for said patient; and
(d) means for generating in said computing device advisory information for one or more therapeutic treatment regimens in said listing based on said patient information and said expert rules.
25. A system according to claim 24, further comprising:
(e) means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) means for generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
26. A system according to claim 24, further comprising:
(f) means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and
(g) means for generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non- recommendation of said therapeutic treatment regimen.
27. A system according to claim 24, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information, and information for drug treatments for other conditions.
28. A system according to claim 24, said patient information including prior therapeutic treatment regimen information.
29. A system according to claim 24, wherein said listing of available therapeutic treatment regimens for said patient comprises a ranked listing of available therapeutic treatment regimens for said patient .
30. A system according to claim 24, wherein said patient information includes prior patient information stored in said computing device.
31. A system according to claim 24, said advisory information including: warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
32. A system according to claim 24, wherein said computing device comprises a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous
; therapeutic treatment regimen information extracted from said fourth knowledge base.
33. A system according to claim 31, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment
> regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
34. A system according to claim 31, wherein said therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine .
35. A system according to claim 31, wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride.
36. A system according to claim 24, wherein said known disease or medical condition is one where multiple prophylactic therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease or medical condition.
37. A system according to claim 24, wherein said known disease or medical condition is a cardiovascular disease.
38. A system according to claim 24, wherein said known disease or medical condition is a pulmonary disease .
39. A system according to claim 24, wherein said known disease or medical condition is a neurologic disease.
40. A system according to claim 24, wherein said known disease or medical condition is cancer.
41. A system according to claim 24, wherein said known disease or medical condition is a urinary tract infection.
42. A system according to claim 24, wherein said known disease or medical condition is hepatitis.
43. A system according to claim 24, wherein said known disease or medical condition is HIV-1 infection.
44. A system according to claim 24, wherein said knowledge base comprises a plurality of different combination therapeutic treatment regimens.
45. A system according to claim 24, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
46. A system according to claim 24, further comprising:
(e) means for accessing, via said computing device, information for one or more therapeutic treatment regimens from a standard drug reference source .
47. A computer program product for guiding the selection of a therapeutic treatment regimen for a patient with a known disease or medical condition, said computer program product comprising a computer usable storage medium having computer readable program code means embodied in the medium, the computer readable program code means comprising:
(a) computer readable program code means for generating a computing device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition; a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition; a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens ; and
(b) computer readable program code means for providing patient information to said computing device; (c) computer readable program code means for generating in said computing device a listing of available therapeutic treatment regimens for said patient; and
(d) computer readable program code means for generating in said computing device advisory information for one or more therapeutic treatment regimens in said listing based on said patient information and said expert rules.
48. A computer program product according to claim 47, further comprising:
(e) computer readable program code means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) computer readable program code means for generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
49. A computer program product according to claim 48, further comprising:
(g) computer readable program code means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and
(h) computer readable program code means for generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
50. A computer program product according to claim 47, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information, and information for drug treatments for other conditions .
51. A computer program product according to claim 47, said patient information including prior therapeutic treatment regimen information.
52. A computer program product according to claim 47, wherein said patient information includes prior patient information stored in said computing device.
53. A computer program product according to claim 47, said advisory information including: warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
54. A computer program product according to claim 47 wherein said computing device comprises a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous therapeutic treatment regimen information extracted from said fourth knowledge base.
55. A computer program product according to claim 53, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
56. A computer program product according to claim 53, wherein said therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine.
57. A computer program product according to claim 53, wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride .
58. A computer program product according to claim 47, wherein said known disease or medical condition is one where multiple prophylactic therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease or medical condition.
59. A computer program product according to claim 47, wherein said known disease or medical condition is a cardiovascular disease.
60. A computer program product according to claim 47, wherein said known disease or medical condition is a pulmonary disease .
61. A computer program product according to claim 47, wherein said known disease or medical condition is a neurologic disease.
62. A computer program product according to claim 47, wherein said known disease or medical condition is cancer.
63. A computer program product according to claim 47, wherein said known disease or medical condition is a urinary tract infection.
64. A computer program product according to claim 47, wherein said known disease or medical condition is hepatitis.
65. A computer program product according to claim 47, wherein said known disease or medical condition is HIV-1 infection.
66. A computer program product according to claim 47, wherein said knowledge base comprises a plurality of different combination therapeutic treatment regimens .
67. A computer program product according to claim 47, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
68. A computer program product according to claim 47, further comprising:
(e) computer readable program code means for accessing, via said computing device, information for 'Γûá> one or more therapeutic treatment regimens from a standard drug reference source .
69. A computer program product according to claim 47, wherein said listing of available therapeutic treatment regimens for said patient is a ranked listing of available therapeutic treatment regimens for said patient.
PCT/US1999/007171 1998-04-03 1999-04-01 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens WO1999052025A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU34617/99A AU750822B2 (en) 1998-04-03 1999-04-01 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
CA2326579A CA2326579C (en) 1998-04-03 1999-04-01 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
BR9909906-3A BR9909906A (en) 1998-04-03 1999-04-01 Computer program systems, methods and products to guide the selection of therapeutic treatment regimens
IL13862099A IL138620A0 (en) 1998-04-03 1999-04-01 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
JP2000542701A JP2002510817A (en) 1998-04-03 1999-04-01 System, method and computer program product for guiding treatment prescription plan selection
EP99916262A EP1068568A4 (en) 1998-04-03 1999-04-01 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8062998P 1998-04-03 1998-04-03
US60/080,629 1998-04-03

Publications (2)

Publication Number Publication Date
WO1999052025A2 true WO1999052025A2 (en) 1999-10-14
WO1999052025A3 WO1999052025A3 (en) 1999-12-02

Family

ID=22158589

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/007171 WO1999052025A2 (en) 1998-04-03 1999-04-01 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens

Country Status (9)

Country Link
US (2) US6081786A (en)
EP (1) EP1068568A4 (en)
JP (2) JP2002510817A (en)
CN (1) CN1304512A (en)
AU (1) AU750822B2 (en)
BR (1) BR9909906A (en)
CA (1) CA2326579C (en)
IL (1) IL138620A0 (en)
WO (1) WO1999052025A2 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001273362A (en) * 2000-03-23 2001-10-05 Toshiba Corp Medical diagnosis supporting method, system therefor, retrieval terminal and medical information terminal for the same
JP2001293058A (en) * 2000-04-14 2001-10-23 Takeo Kawai Method and apparatus for indicating treatment data in musculature zone remedy
US6581038B1 (en) * 1999-03-15 2003-06-17 Nexcura, Inc. Automated profiler system for providing medical information to patients
WO2004015612A1 (en) * 2002-07-31 2004-02-19 Otto Carl Gerntholtz Infectious disease surveillance system
EP1437674A2 (en) 1998-11-30 2004-07-14 Novo Nordisk A/S A method and a system for assisting a user in a medical self treatment
JP2009123233A (en) * 2001-12-28 2009-06-04 Lahteenmaki Pertti System and method for providing recommendation and/or information concerning suitability for nutritional and/or medical ingredients
EP2109056A2 (en) * 2008-04-08 2009-10-14 The Quantum Group, Inc. System and method for dynamic drug interaction analysis and reporting
US20130179181A1 (en) * 2012-01-06 2013-07-11 Molecular Health Systems and methods for personalized de-risking based on patient genome data
US8548937B2 (en) 2010-08-17 2013-10-01 Wisercare Llc Medical care treatment decision support system
WO2013150039A1 (en) * 2012-04-02 2013-10-10 Molecular Health Ag Systems and methods for disease knowledge modeling and clinical decision support
WO2014117873A1 (en) * 2013-01-29 2014-08-07 Molecular Health Ag Systems and methods for clinical decision support
US9050411B2 (en) 2003-11-05 2015-06-09 Baxter International Inc. Dialysis system including downloaded prescription entry
US9081879B2 (en) 2004-10-22 2015-07-14 Clinical Decision Support, Llc Matrix interface for medical diagnostic and treatment advice system and method
US9690905B2 (en) 2008-07-09 2017-06-27 Baxter International Inc. Dialysis treatment prescription system and method
US10016554B2 (en) 2008-07-09 2018-07-10 Baxter International Inc. Dialysis system including wireless patient data
US10061899B2 (en) 2008-07-09 2018-08-28 Baxter International Inc. Home therapy machine
US10173008B2 (en) 2002-01-29 2019-01-08 Baxter International Inc. System and method for communicating with a dialysis machine through a network
US10561780B2 (en) 2008-07-09 2020-02-18 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US10589014B2 (en) 2016-12-21 2020-03-17 Baxter International Inc. Medical fluid delivery system including remote machine updating and control
US10964417B2 (en) 2016-12-21 2021-03-30 Baxter International Inc. Medical fluid delivery system including a mobile platform for patient engagement and treatment compliance

Families Citing this family (423)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030212579A1 (en) * 2002-05-08 2003-11-13 Brown Stephen J. Remote health management system
US5660176A (en) 1993-12-29 1997-08-26 First Opinion Corporation Computerized medical diagnostic and treatment advice system
USRE43433E1 (en) 1993-12-29 2012-05-29 Clinical Decision Support, Llc Computerized medical diagnostic and treatment advice system
US6206829B1 (en) 1996-07-12 2001-03-27 First Opinion Corporation Computerized medical diagnostic and treatment advice system including network access
US5935060A (en) 1996-07-12 1999-08-10 First Opinion Corporation Computerized medical diagnostic and treatment advice system including list based processing
US6673314B1 (en) 1997-02-14 2004-01-06 Nxstage Medical, Inc. Interactive systems and methods for supporting hemofiltration therapies
US6852090B2 (en) 1997-02-14 2005-02-08 Nxstage Medical, Inc. Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
CN1252877A (en) * 1997-03-13 2000-05-10 第一咨询公司 Disease management system
US6697783B1 (en) * 1997-09-30 2004-02-24 Medco Health Solutions, Inc. Computer implemented medical integrated decision support system
US6314384B1 (en) * 1998-03-04 2001-11-06 Gerald E. Goetz Medication management apparatus
US6546545B1 (en) 1998-03-05 2003-04-08 American Management Systems, Inc. Versioning in a rules based decision management system
US6609120B1 (en) 1998-03-05 2003-08-19 American Management Systems, Inc. Decision management system which automatically searches for strategy components in a strategy
US8364578B1 (en) 1998-03-05 2013-01-29 Cgi Technologies And Solutions Inc. Simultaneous customer/account strategy execution in a decision management system
US6601034B1 (en) 1998-03-05 2003-07-29 American Management Systems, Inc. Decision management system which is cross-function, cross-industry and cross-platform
AU750822B2 (en) * 1998-04-03 2002-08-01 Triangle Pharmaceuticals, Inc. Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
US6584445B2 (en) * 1998-10-22 2003-06-24 Computerized Health Evaluation Systems, Inc. Medical system for shared patient and physician decision making
US6314415B1 (en) * 1998-11-04 2001-11-06 Cch Incorporated Automated forms publishing system and method using a rule-based expert system to dynamically generate a graphical user interface
US6269355B1 (en) * 1999-04-15 2001-07-31 Kadiri, Inc. Automated process guidance system and method using knowledge management system
US7750891B2 (en) 2003-04-09 2010-07-06 Tegic Communications, Inc. Selective input system based on tracking of motion parameters of an input device
US7821503B2 (en) 2003-04-09 2010-10-26 Tegic Communications, Inc. Touch screen and graphical user interface
US7286115B2 (en) 2000-05-26 2007-10-23 Tegic Communications, Inc. Directional input system with automatic correction
US7030863B2 (en) * 2000-05-26 2006-04-18 America Online, Incorporated Virtual keyboard system with automatic correction
US20030204426A1 (en) * 1999-06-18 2003-10-30 American Management Systems, Inc. Decision management system which searches for strategy components
US7058517B1 (en) 1999-06-25 2006-06-06 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
EP1208421A4 (en) * 1999-06-25 2004-10-20 Genaissance Pharmaceuticals Methods for obtaining and using haplotype data
US6708155B1 (en) 1999-07-07 2004-03-16 American Management Systems, Inc. Decision management system with automated strategy optimization
US20040215491A1 (en) * 1999-08-23 2004-10-28 Clark Paul T. Providing comprehensive online health-related information and services
US7376700B1 (en) * 1999-08-23 2008-05-20 Wellcoaches Corporation Personal coaching system for clients with ongoing concerns such as weight loss
WO2001022330A1 (en) * 1999-09-23 2001-03-29 Infoscriber Corporation Medical information system and method to obtain reasoning for therapeutic events
US8234099B2 (en) * 1999-10-15 2012-07-31 Hemopet Computer program for determining a nutritional diet product for a canine or feline animal
CA2387780C (en) * 1999-10-15 2011-10-11 W. Jean Dodds Animal health diagnosis
US6730023B1 (en) * 1999-10-15 2004-05-04 Hemopet Animal genetic and health profile database management
US7548839B2 (en) * 1999-10-15 2009-06-16 Hemopet System for animal health diagnosis
US6287254B1 (en) * 1999-11-02 2001-09-11 W. Jean Dodds Animal health diagnosis
US20050090718A1 (en) * 1999-11-02 2005-04-28 Dodds W J. Animal healthcare well-being and nutrition
US6876991B1 (en) 1999-11-08 2005-04-05 Collaborative Decision Platforms, Llc. System, method and computer program product for a collaborative decision platform
US7780619B2 (en) * 1999-11-29 2010-08-24 Nxstage Medical, Inc. Blood treatment apparatus
US20040204964A1 (en) * 1999-12-06 2004-10-14 Moore Erik Andrew Method and apparatus for importing healthcare related information from a physician office management information system
US6539250B1 (en) * 1999-12-15 2003-03-25 David S. Bettinger Programmable transdermal therapeutic apparatus
US8352289B2 (en) * 1999-12-30 2013-01-08 Dhi Computing, Inc. Systems and methods for providing and maintaining electronic medical records
US7774210B1 (en) * 1999-12-30 2010-08-10 DHI Computing Service, Inc. Method and system for recording and maintaining patient history data as well as generating concurrent billing records
CA2396573A1 (en) * 2000-01-06 2001-07-12 Igotpain.Com, Inc. System and method of decision making
CA2399011A1 (en) * 2000-01-28 2001-08-02 Acurian, Inc. Systems and methods for selecting and recruiting investigators and subjects for clinical studies
UA73967C2 (en) * 2000-02-14 2005-10-17 First Opinion Corp Structure-based automatic processing for diagnostics (variants)
AU2001240128A1 (en) * 2000-03-10 2001-09-24 Medidata Solutions, Inc. Method of conducting secure clinical trials and guaranteeing the occurrence of an event
WO2001072208A2 (en) * 2000-03-29 2001-10-04 University Of Virginia Patent Foundation Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
US6687685B1 (en) * 2000-04-07 2004-02-03 Dr. Red Duke, Inc. Automated medical decision making utilizing bayesian network knowledge domain modeling
GB2384890A (en) * 2000-05-09 2003-08-06 Fair Isaac And Company Approach for re-using business rules
US8301468B2 (en) * 2000-05-15 2012-10-30 Optuminsight, Inc. System and method of drug disease matching
US7801591B1 (en) 2000-05-30 2010-09-21 Vladimir Shusterman Digital healthcare information management
US9183351B2 (en) 2000-05-30 2015-11-10 Vladimir Shusterman Mobile system with network-distributed data processing for biomedical applications
US8388530B2 (en) 2000-05-30 2013-03-05 Vladimir Shusterman Personalized monitoring and healthcare information management using physiological basis functions
US7485095B2 (en) * 2000-05-30 2009-02-03 Vladimir Shusterman Measurement and analysis of trends in physiological and/or health data
US7444293B1 (en) * 2000-05-31 2008-10-28 Fasttrack Systems, Inc. Protocol disambiguation using a model-based methodology
IL152740A0 (en) 2000-05-31 2003-06-24 Fasttrack Systems Inc Clinical trials management system and method
US7337123B2 (en) * 2000-06-26 2008-02-26 Epic Systems Corporation Rules based ticketing for self-scheduling of appointments
US6931326B1 (en) 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US8688474B2 (en) * 2000-06-26 2014-04-01 Epic Systems Corporation Patient health record access system
US20020072933A1 (en) * 2000-06-30 2002-06-13 Vonk Glenn Philander Health outcomes and disease management network and related method for providing improved patient care
US6742895B2 (en) * 2000-07-06 2004-06-01 Alan L. Robin Internet-based glaucoma diagnostic system
GB2368428B (en) * 2000-07-15 2005-02-23 Andrew William Bodsworth Method for optimising pharmaceutical prescribing
US7567870B1 (en) 2000-07-31 2009-07-28 Institute For Systems Biology Multiparameter analysis for predictive medicine
EP1358745B1 (en) * 2000-08-22 2008-12-10 Medtronic, Inc. Medical device systems implemented network system for remote patient management
EP1328806A2 (en) * 2000-09-15 2003-07-23 Virco N.V. System and method for optimizing drug therapy for the treatment of diseases
US7251610B2 (en) * 2000-09-20 2007-07-31 Epic Systems Corporation Clinical documentation system for use by multiple caregivers
US8050944B2 (en) * 2000-09-20 2011-11-01 Epic Systems Corporation Intelligent patient visit information management and navigation system
US7447643B1 (en) 2000-09-21 2008-11-04 Theradoc.Com, Inc. Systems and methods for communicating between a decision-support system and one or more mobile information devices
WO2002025528A1 (en) 2000-09-21 2002-03-28 Theradoc.Com, Inc. Systems and methods for manipulating medical data via a decision support system
US20020095313A1 (en) * 2000-09-28 2002-07-18 Haq Mohamed M. Computer system for assisting a physician
US6988088B1 (en) * 2000-10-17 2006-01-17 Recare, Inc. Systems and methods for adaptive medical decision support
US6871171B1 (en) * 2000-10-19 2005-03-22 Optimata Ltd. System and methods for optimized drug delivery and progression of diseased and normal cells
US20020116222A1 (en) * 2000-10-22 2002-08-22 Standing Stone, Inc. Method and system for administering anticoagulation therapy
US20100211411A1 (en) * 2000-10-31 2010-08-19 Emergingmed.Com System and method for matching users with a service provider, program, or program site based on detailed acceptance criteria
US7711580B1 (en) 2000-10-31 2010-05-04 Emergingmed.Com System and method for matching patients with clinical trials
JP2004517394A (en) * 2000-11-02 2004-06-10 エピゲノミクス アーゲー System, method and computer program for guiding the selection of a therapy based on DNA methylation status
US20060136142A1 (en) * 2000-11-02 2006-06-22 Kurt Berlin Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA
US20020055918A1 (en) * 2000-11-08 2002-05-09 Patrick Hlathein Operating room resource management system incorporating an interactive, visual method for coordinating multiple, interdependent
AU2002239758A1 (en) * 2000-11-10 2002-06-11 Medidata Solutions, Inc. Method and apparatus of assuring informed consent while conducting secure clinical trials
US20020082870A1 (en) * 2000-11-20 2002-06-27 Mark Penny System and method for processing patient medical information
CN1290053C (en) * 2000-11-22 2006-12-13 里科尔公司 Systems and methods for integrating disease management into physician workflow
US20050107672A1 (en) * 2000-11-22 2005-05-19 Recare, Inc. System and method for external input of disease management algorithm
US8301462B2 (en) * 2000-11-22 2012-10-30 Catalis, Inc. Systems and methods for disease management algorithm integration
US7275220B2 (en) 2000-12-22 2007-09-25 Epic Systems Corporation System and method for a seamless user interface for an integrated electronic health care information system
US20020120472A1 (en) * 2000-12-22 2002-08-29 Dvorak Carl D. System and method for integration of health care records
US6983423B2 (en) * 2000-12-22 2006-01-03 Epic Systems Corporation Electronic system for collecting and communicating clinical order information in an acute care setting
US7181285B2 (en) 2000-12-26 2007-02-20 Cardiac Pacemakers, Inc. Expert system and method
US20030097185A1 (en) * 2000-12-29 2003-05-22 Goetzke Gary A. Chronic pain patient medical resources forecaster
US7373306B1 (en) 2000-12-29 2008-05-13 General Electric Capital Corporation Systems and methods for tracking employee leaves under the FMLA
US20020128866A1 (en) * 2000-12-29 2002-09-12 Goetzke Gary A. Chronic pain patient care plan
US20020128860A1 (en) * 2001-01-04 2002-09-12 Leveque Joseph A. Collecting and managing clinical information
US7412396B1 (en) 2001-02-15 2008-08-12 Haq Mohamed M Virtual clinic for medical practice
US20060235623A1 (en) * 2001-01-19 2006-10-19 Patrick Rambaud Method of processing biological analysis data and expert system of biological analysis applying this method
US20030014222A1 (en) * 2001-02-28 2003-01-16 Klass David B. Method and system for monitoring patient care
US20020138746A1 (en) * 2001-03-23 2002-09-26 Mark Buttner Method of generating a secure output file
US20020138636A1 (en) * 2001-03-23 2002-09-26 Mark Buttner Method for automatically mass generating personalized data report outputs
US20020143579A1 (en) * 2001-03-30 2002-10-03 Docherty John P. System and method for targeted interventions of physician prescription practices based on deviations from expert guidelines
US7181413B2 (en) 2001-04-18 2007-02-20 Capital Analytics, Inc. Performance-based training assessment
US20020187483A1 (en) * 2001-04-20 2002-12-12 Cerner Corporation Computer system for providing information about the risk of an atypical clinical event based upon genetic information
US7542961B2 (en) * 2001-05-02 2009-06-02 Victor Gogolak Method and system for analyzing drug adverse effects
US7925612B2 (en) * 2001-05-02 2011-04-12 Victor Gogolak Method for graphically depicting drug adverse effect risks
US6778994B2 (en) * 2001-05-02 2004-08-17 Victor Gogolak Pharmacovigilance database
US20020165898A1 (en) * 2001-05-03 2002-11-07 Joe Duffy Recipient-determined method for sharing tasks in an advanced electronic messaging/workflow system
US20020173993A1 (en) * 2001-05-10 2002-11-21 Decode Genetics Ehf. Corporation Drug advice expert
US7395214B2 (en) * 2001-05-11 2008-07-01 Craig P Shillingburg Apparatus, device and method for prescribing, administering and monitoring a treatment regimen for a patient
US20040015810A1 (en) * 2001-05-23 2004-01-22 Swinney Robert S. Method for the improved provision of medical services
DE10126715A1 (en) * 2001-05-31 2002-12-12 Siemens Ag System for automated risk modification in risk groups
EP1395289B1 (en) * 2001-06-07 2010-12-15 Christine Dr. Sang Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists
EP1399867A2 (en) * 2001-06-26 2004-03-24 Siemens Aktiengesellschaft Expert system for uncovering counter-indications in case of limited access to patient data
WO2003003267A1 (en) * 2001-06-29 2003-01-09 Nutrition Act.Co., Ltd. Nutrition demand calculating apparatus, nutrition supplementary ingredient proposing apparatus, nutrition supplementary ingredient blending apparatus, and nutrition supplementary ingredient blending system
US20030017440A1 (en) * 2001-07-18 2003-01-23 The Procter & Gamble Company Methods for improving patient compliance with a treatment regimen
US7343247B2 (en) * 2001-07-30 2008-03-11 The Institute For Systems Biology Methods of classifying drug responsiveness using multiparameter analysis
US20030061073A1 (en) * 2001-08-01 2003-03-27 Khiang Seow Method and system for displaying patient information
US20030125609A1 (en) * 2001-08-03 2003-07-03 Robert Becker Method for reliable measurement in medical care and patient self monitoring
US20030143572A1 (en) * 2001-08-13 2003-07-31 Lu Mou-Ying Fu Molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer
WO2003017174A1 (en) * 2001-08-16 2003-02-27 Wharton Robert H Pictorial integrated prescription system
CN1311781C (en) * 2001-08-20 2007-04-25 因弗内斯医疗有限公司 Wireless diabetes management devices and methods for using the same
US20030060691A1 (en) * 2001-08-24 2003-03-27 Olympus Optical Co., Ltd. Examination follow-up information management apparatus for performing the simple and certain follow-up examinations
US7461006B2 (en) * 2001-08-29 2008-12-02 Victor Gogolak Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
US20030046111A1 (en) * 2001-08-31 2003-03-06 American Medical Systems System and method for treating pelvic floor disorders
US20030046113A1 (en) * 2001-08-31 2003-03-06 Johnson Ann Mond Method and system for consumer healthcare decisionmaking
US6802810B2 (en) * 2001-09-21 2004-10-12 Active Health Management Care engine
US20030065669A1 (en) * 2001-10-03 2003-04-03 Fasttrack Systems, Inc. Timeline forecasting for clinical trials
US7983848B2 (en) * 2001-10-16 2011-07-19 Cerner Innovation, Inc. Computerized method and system for inferring genetic findings for a patient
US7904314B2 (en) * 2001-10-17 2011-03-08 Siemens Medical Solutions Usa, Inc. System and method for ordering patient specific healthcare services
US7418374B2 (en) * 2001-10-25 2008-08-26 Optimata Treatment protocol generation for diseases related to angiogenesis
US7315725B2 (en) * 2001-10-26 2008-01-01 Concordant Rater Systems, Inc. Computer system and method for training certifying or monitoring human clinical raters
JP2005509218A (en) * 2001-11-02 2005-04-07 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Patient data mining to maintain quality
US8949082B2 (en) 2001-11-02 2015-02-03 Siemens Medical Solutions Usa, Inc. Healthcare information technology system for predicting or preventing readmissions
US7383088B2 (en) * 2001-11-07 2008-06-03 Cardiac Pacemakers, Inc. Centralized management system for programmable medical devices
US20030154110A1 (en) * 2001-11-20 2003-08-14 Ervin Walter Method and apparatus for wireless access to a health care information system
US20030130872A1 (en) * 2001-11-27 2003-07-10 Carl Dvorak Methods and apparatus for managing and using inpatient healthcare information
US7577573B2 (en) * 2001-12-12 2009-08-18 General Electric Company Medical support system
US7457731B2 (en) * 2001-12-14 2008-11-25 Siemens Medical Solutions Usa, Inc. Early detection of disease outbreak using electronic patient data to reduce public health threat from bio-terrorism
US20040267458A1 (en) * 2001-12-21 2004-12-30 Judson Richard S. Methods for obtaining and using haplotype data
US20030135393A1 (en) * 2002-01-11 2003-07-17 Laboratory Corporation Of America Holdings System, method and computer program product for improving treatment of medical patients
US20030181792A1 (en) * 2002-01-18 2003-09-25 Robert Seyko Healthcare outcome measurement, analysis and improvement system
US20030171657A1 (en) * 2002-01-22 2003-09-11 Ralph Leonard Selection of optimal medication methodology (SOOMM)
US7623969B2 (en) * 2002-01-31 2009-11-24 The Institute For Systems Biology Gene discovery for the system assignment of gene function
US20040205576A1 (en) * 2002-02-25 2004-10-14 Chikirivao Bill S. System and method for managing Knowledge information
US20030216945A1 (en) * 2002-03-25 2003-11-20 Dvorak Carl D. Method for analyzing orders and automatically reacting to them with appropriate responses
US20030220815A1 (en) * 2002-03-25 2003-11-27 Cathy Chang System and method of automatically determining and displaying tasks to healthcare providers in a care-giving setting
US20030220821A1 (en) * 2002-04-30 2003-11-27 Ervin Walter System and method for managing and reconciling asynchronous patient data
US20030220816A1 (en) * 2002-04-30 2003-11-27 Andy Giesler System and method for managing interactions between machine-generated and user-defined patient lists
US20030208380A1 (en) * 2002-05-06 2003-11-06 Honeycutt Sarah L. System and method for delivering comprehensive health care
US6830575B2 (en) * 2002-05-08 2004-12-14 Scimed Life Systems, Inc. Method and device for providing full protection to a stent
US20030220817A1 (en) * 2002-05-15 2003-11-27 Steve Larsen System and method of formulating appropriate subsets of information from a patient's computer-based medical record for release to various requesting entities
US7693727B2 (en) * 2002-05-16 2010-04-06 Cerylion, Inc. Evidence-based checklist flow and tracking system for patient care by medical providers
US20040010422A1 (en) * 2002-05-20 2004-01-15 Cliff Michalski Method and apparatus for batch-processed invoicing
US20040010465A1 (en) * 2002-05-20 2004-01-15 Cliff Michalski Method and apparatus for exception based payment posting
US7624029B1 (en) * 2002-06-12 2009-11-24 Anvita, Inc. Computerized system and method for rapid data entry of past medical diagnoses
US7698157B2 (en) * 2002-06-12 2010-04-13 Anvita, Inc. System and method for multi-dimensional physician-specific data mining for pharmaceutical sales and marketing
US20060095270A1 (en) * 2002-06-21 2006-05-04 Joseph Somerville Brand/generic classification system
EP1378853A1 (en) * 2002-07-04 2004-01-07 GE Medical Systems Global Technology Company LLC Digital medical assistance system
AU2003253953A1 (en) * 2002-07-17 2004-02-02 Deborah L. Darazs Method and system for providing information to physicians
US7979294B2 (en) * 2002-07-31 2011-07-12 Epic Systems Corporation System and method for providing decision support to appointment schedulers in a healthcare setting
US20030088365A1 (en) * 2002-08-01 2003-05-08 Robert Becker System and method of drug development for selective drug use with individual, treatment responsive patients, and applications of the method in medical care
ES2456068T3 (en) * 2002-08-13 2014-04-21 University Of Virginia Patent Foundation Method, system and software product for glycemia self-monitoring (SMBG) data processing to improve diabetic self-management
DE10237348A1 (en) * 2002-08-14 2003-11-13 Siemens Ag Medical examination suggestion method in which a computer is used to compare a patient profile with a profile database, so that when the patient is in an examination department, additional examinations can be carried out
ES2590134T3 (en) * 2002-08-15 2016-11-18 Pacific Edge Limited Medical decision support systems that use gene expression and clinical information, and method of use
US20040044654A1 (en) * 2002-08-29 2004-03-04 Ballenger Eric S. Methods for recruiting patients for clinical studies
US7680086B2 (en) * 2002-09-09 2010-03-16 Siemens Canada Limited Wireless local area network with clients having extended freedom of movement
US8489336B2 (en) 2002-09-16 2013-07-16 Optimata Ltd. Techniques for purposing a new compound and for re-purposing a drug
AU2003269395A1 (en) * 2002-09-16 2004-04-30 Optimata, Ltd. An interactive technique for optimizing drug development from the pre-clinical phases through phase-iv
US20040172520A1 (en) * 2002-09-19 2004-09-02 Michael Smit Methods and apparatus for visually creating complex expressions that inform a rules-based system of clinical decision support
US20050283386A1 (en) * 2002-11-20 2005-12-22 Aventis Pharmaceuticals Inc. Method and system for marketing a treatment regimen
AU2003283749A1 (en) * 2002-12-20 2004-07-14 Koninklijke Philips Electronics N.V. Method for determining normal measurements for a patient
US7136707B2 (en) 2003-01-21 2006-11-14 Cardiac Pacemakers, Inc. Recordable macros for pacemaker follow-up
US7230529B2 (en) * 2003-02-07 2007-06-12 Theradoc, Inc. System, method, and computer program for interfacing an expert system to a clinical information system
JP5348840B2 (en) 2003-02-20 2013-11-20 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ How to choose a drug
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
SE0300893D0 (en) * 2003-03-28 2003-03-28 Saab Ab Device, use, system and storage medium regarding decision support or control of an entity's actions
US7260480B1 (en) * 2003-04-07 2007-08-21 Health Hero Network, Inc. Method and system for integrating feedback loops in medical knowledge development and healthcare management
US7543149B2 (en) * 2003-04-22 2009-06-02 Ge Medical Systems Information Technologies Inc. Method, system and computer product for securing patient identity
US20040267570A1 (en) * 2003-04-23 2004-12-30 Becker Robert E. Method for information and management system for health care
US7780595B2 (en) 2003-05-15 2010-08-24 Clinical Decision Support, Llc Panel diagnostic method and system
DE10322685A1 (en) * 2003-05-20 2004-12-23 Siemens Ag Process for processing a data set comprising therapy instructions for medical treatments
US20050015279A1 (en) * 2003-05-21 2005-01-20 Rucker Donald W. Service order system and user interface for use in healthcare and other fields
US8504380B2 (en) * 2003-06-05 2013-08-06 Medidata Solutions, Inc. Assistance for clinical trial protocols
US20050010444A1 (en) * 2003-06-06 2005-01-13 Iliff Edwin C. System and method for assisting medical diagnosis using an anatomic system and cause matrix
US20040260576A1 (en) * 2003-06-20 2004-12-23 Dongwen Wang Guideline execution task ontology (GETO)
WO2005002057A2 (en) * 2003-06-23 2005-01-06 On Command Corporation Hybrid data distribution systems
JP2007500379A (en) * 2003-07-25 2007-01-11 ヤマハ発動機株式会社 Software optimization device for intelligent control system
US20050038675A1 (en) * 2003-08-12 2005-02-17 Siekman Jeffrey A. Methods and systems for at-home and community-based care
WO2005029252A2 (en) * 2003-09-15 2005-03-31 Idx Systems Corporation Executing clinical practice guidelines
US20050059894A1 (en) * 2003-09-16 2005-03-17 Haishan Zeng Automated endoscopy device, diagnostic method, and uses
US8825502B2 (en) * 2003-09-30 2014-09-02 Epic Systems Corporation System and method for providing patient record synchronization in a healthcare setting
US20050071195A1 (en) * 2003-09-30 2005-03-31 Cassel David A. System and method of synchronizing data sets across distributed systems
US7240039B2 (en) * 2003-10-29 2007-07-03 Hewlett-Packard Development Company, L.P. System and method for combining valuations of multiple evaluators
US20050159985A1 (en) * 2003-11-21 2005-07-21 Bertram Carl T. System and method of stratifying intervention groups and comparison groups based on disease severity index scores and ranges
US20060047435A1 (en) * 2004-08-24 2006-03-02 Ishikawa Muriel Y System and method related to augmenting an immune system
US20060095211A1 (en) * 2003-12-05 2006-05-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System and method for modulating a cell mediated immune response
US20060047436A1 (en) * 2004-08-25 2006-03-02 Ishikawa Muriel Y System and method for magnifying an immune response
US20060047433A1 (en) * 2004-08-24 2006-03-02 Ishikawa Muriel Y System and method related to enhancing an immune system
US20060122783A1 (en) * 2004-08-24 2006-06-08 Ishikawa Muriel Y System and method for heightening a humoral immune response
US20060122784A1 (en) * 2004-12-03 2006-06-08 Ishikawa Muriel Y System and method for augmenting a humoral immune response
US20060116824A1 (en) * 2004-12-01 2006-06-01 Ishikawa Muriel Y System and method for modulating a humoral immune response
US20060047437A1 (en) * 2004-08-25 2006-03-02 Ishikawa Muriel Y System and method for heightening an immune response
US20060047434A1 (en) * 2004-08-24 2006-03-02 Ishikawa Muriel Y System and method related to improving an immune system
US20060182742A1 (en) * 2004-08-24 2006-08-17 Ishikawa Muriel Y System and method for magnifying a humoral immune response
US20090240529A1 (en) * 2003-12-27 2009-09-24 Enhanced Care Initiatives, Inc. Method for selecting a high risk patient for participation in a care management program for patients having poor prognoses
US20050149362A1 (en) * 2003-12-30 2005-07-07 Peterson Per A. System and method for visually presenting digital patient information for future drug use resulting from dosage alteration
US20060143022A1 (en) * 2004-01-13 2006-06-29 Betty Bird Consumer care management method and system
ZA200605829B (en) * 2004-01-16 2007-11-28 Disease Man Services Plc Disease Management System
US20060080140A1 (en) * 2004-02-09 2006-04-13 Epic Systems Corporation System and method for providing a clinical summary of patient information in various health care settings
US7251638B2 (en) * 2004-03-03 2007-07-31 Yamaha Hatsudoki Kabushiki Kaisha Intelligent robust control system for motorcycle using soft computing optimizer
US20050216306A1 (en) * 2004-03-24 2005-09-29 Benjamin Atkinson Evidence-based extender system
US20050234741A1 (en) * 2004-04-16 2005-10-20 Sumit Rana Electronic appointment scheduling for medical resources
US8428968B2 (en) * 2004-05-10 2013-04-23 Epic Systems Corporation Interactive system for patient access to electronic medical records
US8135595B2 (en) * 2004-05-14 2012-03-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Computer systems and methods for providing health care
US20060004605A1 (en) * 2004-06-21 2006-01-05 Epic Systems Corporation System and method for a comprehensive interactive graphical representation of a health care facility for managing patient care and health care facility resources
US20050283387A1 (en) * 2004-06-21 2005-12-22 Epic Systems Corporation System for providing an interactive anatomical graphical representation of a body for use in a health care environment
US8060315B2 (en) * 2004-07-27 2011-11-15 Carefusion 303, Inc. Method for measuring the incidence of hospital acquired infections
US20070265788A1 (en) * 2004-08-24 2007-11-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems for augmenting cell-mediated immune response
US20070265787A1 (en) * 2004-08-24 2007-11-15 Searete Llc,A Limited Liability Corporation Of The State Of Delaware Computational methods and systems for magnifying cell-mediated immune response
US20070265817A1 (en) * 2004-08-24 2007-11-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods relating to fortifying an immune system
US20070265818A1 (en) * 2004-08-24 2007-11-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems for heightening cell-mediated immune response
US20070207492A1 (en) * 2004-08-24 2007-09-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems to adjust a humoral immune response
US20070196362A1 (en) * 2004-08-24 2007-08-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems to bolster an immune response
US20070288173A1 (en) * 2004-08-24 2007-12-13 Searete Llc, A Limited Liability Corporation Of The State Of Delware Computational methods and systems to reinforce a humoral immune response
US20060047439A1 (en) * 2004-08-24 2006-03-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System and method for improving a humoral immune response
US20060257395A1 (en) * 2005-05-16 2006-11-16 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System and method for magnifying a humoral immune response
US20060047554A1 (en) * 2004-08-24 2006-03-02 Steven Larsen Rules based resource scheduling
US20070198196A1 (en) * 2004-08-24 2007-08-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods relating to ameliorating an immune system
US20070265819A1 (en) * 2004-08-24 2007-11-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems for improving cell-mediated immune response
US8725547B2 (en) 2004-08-24 2014-05-13 Epic Systems Corporation Utilization indicating schedule scanner
US20060047539A1 (en) * 2004-08-31 2006-03-02 Paul Huang Healthcare administration transaction method and system for the same
US20060053034A1 (en) * 2004-09-08 2006-03-09 Epic Systems Corporation System and method for providing a real-time status for managing encounters in health care settings
US7762181B2 (en) * 2004-10-01 2010-07-27 Fonterra Co-Operative Group Limited Customised nutritional food and beverage dispensing system
US20060085222A1 (en) * 2004-10-14 2006-04-20 Paul Huang Healthcare administration transaction method and system for the same
US20060085381A1 (en) * 2004-10-20 2006-04-20 Epic Systems Corporation Remote deployment access system and method
US20060095315A1 (en) * 2004-10-29 2006-05-04 Sbc Knowledge Ventures L.P. Method and apparatus for a mechanized attendance management system
WO2006058103A2 (en) * 2004-11-24 2006-06-01 Siemens Medical Solutions Usa, Inc. A predictive user interface system
US20060117021A1 (en) * 2004-11-29 2006-06-01 Epic Systems Corporation Shared account information method and apparatus
US7747392B2 (en) * 2004-12-14 2010-06-29 Genomas, Inc. Physiogenomic method for predicting clinical outcomes of treatments in patients
US20060278241A1 (en) * 2004-12-14 2006-12-14 Gualberto Ruano Physiogenomic method for predicting clinical outcomes of treatments in patients
ITBO20050002A1 (en) * 2005-01-04 2006-07-05 Giacomo Vespasiani METHOD AND SYSTEM FOR INTERACTIVE MANAGEMENT OF DATA CONCERNING AN INSULIN THERAPY IN SELF-CONTROL FOR A DIABETIC PATIENT
US8140370B2 (en) * 2005-01-20 2012-03-20 Epic Systems Corporation System and method for reducing the steps involved in searching for available appointment times and scheduling appointments in a health care environment
US20060224547A1 (en) * 2005-03-24 2006-10-05 Ulyanov Sergey V Efficient simulation system of quantum algorithm gates on classical computer based on fast algorithm
US20060218108A1 (en) * 2005-03-24 2006-09-28 Sergey Panfilov System for soft computing simulation
US20080275731A1 (en) * 2005-05-18 2008-11-06 Rao R Bharat Patient data mining improvements
US20060293817A1 (en) * 2005-06-23 2006-12-28 Takahide Hagiwara Intelligent electronically-controlled suspension system based on soft computing optimizer
US20070021977A1 (en) * 2005-07-19 2007-01-25 Witt Biomedical Corporation Automated system for capturing and archiving information to verify medical necessity of performing medical procedure
US8751264B2 (en) 2005-07-28 2014-06-10 Beraja Ip, Llc Fraud prevention system including biometric records identification and associated methods
US20160328812A9 (en) * 2005-07-28 2016-11-10 Roberto Beraja Medical decision system including question mapping and cross referencing system and associated methods
US8583454B2 (en) 2005-07-28 2013-11-12 Beraja Ip, Llc Medical claims fraud prevention system including photograph records identification and associated methods
US8392211B2 (en) * 2005-07-28 2013-03-05 Roberto Beraja Medical claims fraud prevention system including patient call initiating feature and associated methods
US8392210B2 (en) * 2005-07-28 2013-03-05 Roberto Beraja Medical claims fraud prevention system and associated methods
US7464042B2 (en) * 2005-07-28 2008-12-09 Roberto Beraja Medical professional monitoring system and associated methods
US8392213B2 (en) * 2005-07-28 2013-03-05 Roberto Beraja Medical claims fraud prevention system including historical patient locating feature and associated methods
US8392212B2 (en) * 2005-07-28 2013-03-05 Roberto Beraja Medical claims fraud prevention system including patient identification interface feature and associated methods
US20070094133A1 (en) * 2005-10-20 2007-04-26 Sudhir Anandarao Systems and methods for managing an expenditure cycle
US20070203746A1 (en) * 2005-10-24 2007-08-30 Siemens Medical Solutions Health Services Corporation System and user interface enabling user order item selection for medical and other fields
EP1955190B1 (en) * 2005-11-10 2018-08-29 In Silico Biosciences, Inc. Method and apparatus for computer modeling the human brain for predicting drug effects
US20100305975A1 (en) * 2005-11-14 2010-12-02 Kantilal Kasan Daya Pharmaceutical Packaging and Method for Delivery of Same
US20070112593A1 (en) * 2005-11-14 2007-05-17 Rxcera Pharmaceutical, Inc. Selection system, dispensing system and treatment with a one-a-day combination pill for hypertension, hypercholesterolemia, hypertriglyceridemia and anti-platelet treatment
US20070112589A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware User interface for providing assistance related to health
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US8468029B2 (en) * 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US8532938B2 (en) * 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070119928A1 (en) * 2005-11-17 2007-05-31 Jung Edward K Generating a nutraceutical request from an inventory
WO2007061707A2 (en) * 2005-11-17 2007-05-31 Searete Llc Research in providing assistance related to health
JP2009517186A (en) * 2005-11-29 2009-04-30 チルドレンズ ホスピタル メディカル センター Drug selection and medication optimization and personalization
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080004909A1 (en) * 2005-11-30 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems related to nutraceuticals
US7974856B2 (en) * 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070124175A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20070299693A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Customized visual marking for medication labeling
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
RU2477078C2 (en) * 2006-01-05 2013-03-10 Юниверсити Оф Вирджиния Пэйтент Фаундейшн Method, system and software product for estimating changeability of glucose content in blood in case of diabetes by self-control data
US20070173971A1 (en) * 2006-01-26 2007-07-26 Prairiestone Pharmacy, Llc System and method of providing medication compliance packaging
US7752060B2 (en) 2006-02-08 2010-07-06 Health Grades, Inc. Internet system for connecting healthcare providers and patients
US20070260631A1 (en) * 2006-03-09 2007-11-08 Microsoft Corporation Embedded decision support
US20070239488A1 (en) * 2006-04-05 2007-10-11 Derosso Robert Computerized dental patient record
US8112292B2 (en) 2006-04-21 2012-02-07 Medtronic Navigation, Inc. Method and apparatus for optimizing a therapy
US8380539B2 (en) * 2006-05-09 2013-02-19 University Of Louisville Research Foundation, Inc. Personalized medicine management software
US20070276197A1 (en) * 2006-05-24 2007-11-29 Lifescan, Inc. Systems and methods for providing individualized disease management
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080015549A1 (en) * 2006-07-17 2008-01-17 Siemens Medical Solutions Usa, Inc. System For Processing Medication Restriction Information
US8478605B2 (en) * 2006-07-17 2013-07-02 Walgreen Co. Appropriateness of a medication therapy regimen
US8700430B2 (en) * 2006-07-17 2014-04-15 Walgreen Co. Optimization of a medication therapy regimen
US20080015893A1 (en) * 2006-07-17 2008-01-17 Walgreen Co. Identification of Inappropriate Medications In A Medication Therapy Regimen
US20080126130A1 (en) * 2006-07-17 2008-05-29 Walgreen Co. Compliance With A Medication Therapy Regimen
US20080015894A1 (en) * 2006-07-17 2008-01-17 Walgreen Co. Health Risk Assessment Of A Medication Therapy Regimen
WO2008021186A2 (en) * 2006-08-10 2008-02-21 Global Grid, Llc Web based integrated information system for sharing patient medical information cross-organizationally
AU2007286708B2 (en) * 2006-08-22 2012-07-12 Lead Horse Technologies, Inc. Medical assessment support system and method
US8122432B2 (en) * 2006-10-04 2012-02-21 International Business Machines Corporation Rule management using a configuration database
US20080121743A1 (en) * 2006-11-29 2008-05-29 Fleckten Eric T System For Pneumatically Conveying Particulate Material
US20080154513A1 (en) * 2006-12-21 2008-06-26 University Of Virginia Patent Foundation Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes
WO2008094790A1 (en) * 2007-01-30 2008-08-07 Global Grid, Llc Method and apparatus for internet-based community of health experts
US8225203B2 (en) 2007-02-01 2012-07-17 Nuance Communications, Inc. Spell-check for a keyboard system with automatic correction
US8201087B2 (en) 2007-02-01 2012-06-12 Tegic Communications, Inc. Spell-check for a keyboard system with automatic correction
US20080235053A1 (en) * 2007-03-20 2008-09-25 Pinaki Ray Communication medium for diabetes management
US8758245B2 (en) * 2007-03-20 2014-06-24 Lifescan, Inc. Systems and methods for pattern recognition in diabetes management
US20080234943A1 (en) * 2007-03-20 2008-09-25 Pinaki Ray Computer program for diabetes management
EP2147385A2 (en) * 2007-04-13 2010-01-27 Koninklijke Philips Electronics N.V. Method and system for determining correlation between clinical events
US8694441B1 (en) 2007-09-04 2014-04-08 MDX Medical, Inc. Method for determining the quality of a professional
JP2011501276A (en) * 2007-10-12 2011-01-06 ペイシェンツライクミー, インコーポレイテッド Self-improvement methods using online communities to predict health-related outcomes
US20090119130A1 (en) * 2007-11-05 2009-05-07 Zebadiah Kimmel Method and apparatus for interpreting data
US8447778B2 (en) 2007-11-15 2013-05-21 Siemens Medical Solutions Usa, Inc. Adaptively optimizing order entry system
CN102016786A (en) * 2008-02-22 2011-04-13 领头马科技股份有限公司 Automated ontology generation system and method
US20090240127A1 (en) * 2008-03-20 2009-09-24 Lifescan, Inc. Methods of determining pre or post meal time slots or intervals in diabetes management
US20090307006A1 (en) * 2008-06-04 2009-12-10 International Business Machines Corporation Method of collaborative evaluation infrastructure to assess the quality of healthcare clnical decision actors
US8168063B2 (en) 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
RU2529381C2 (en) * 2008-08-15 2014-09-27 Конинклейке Филипс Электроникс Н.В. Formation of improved image model
US8589178B2 (en) * 2008-09-10 2013-11-19 Roche Diagnostics Operations, Inc. Extensible therapy delivery system and method thereof
US8554579B2 (en) 2008-10-13 2013-10-08 Fht, Inc. Management, reporting and benchmarking of medication preparation
EP2347008B1 (en) * 2008-10-20 2022-06-29 Epitome Pharmaceuticals Limited Methods and systems for improved pharmaceutical intervention in coagulation control
CN102203786A (en) * 2008-11-06 2011-09-28 皇家飞利浦电子股份有限公司 Executable clinical guideline and guideline tool
CN102203784B (en) * 2008-11-06 2019-06-04 皇家飞利浦电子股份有限公司 Dynamic clinical worklist
US7799532B2 (en) * 2008-11-12 2010-09-21 Hemopet Detection and measurement of thyroid hormone autoantibodies
US7794954B2 (en) 2008-11-12 2010-09-14 Hemopet Detection and measurement of thyroid analyte profile
US8012769B2 (en) * 2008-11-12 2011-09-06 Hemopet Thyroid analyte detection and measurement
DE102008057910B4 (en) * 2008-11-18 2010-10-07 P&L Edv Systeme Gmbh Patient management system with intelligent interface device for the transfer of medical data
US7873482B2 (en) * 2008-12-16 2011-01-18 Bruno Stefanon Diagnostic system for selecting nutrition and pharmacological products for animals
US20100151062A1 (en) * 2008-12-16 2010-06-17 Bruno Stefanon Determining nutrients for animals through gene expression
US20100274579A1 (en) * 2009-04-22 2010-10-28 Christian Marten Dynamic, Interactive, Web-Based Treatment System
EP2430574A1 (en) 2009-04-30 2012-03-21 Patientslikeme, Inc. Systems and methods for encouragement of data submission in online communities
US10241644B2 (en) 2011-06-03 2019-03-26 Apple Inc. Actionable reminder entries
US20120311585A1 (en) 2011-06-03 2012-12-06 Apple Inc. Organizing task items that represent tasks to perform
US9687639B1 (en) 2009-06-28 2017-06-27 Ronald Charles Krosky Medical treatment
US20100332445A1 (en) * 2009-06-30 2010-12-30 Lifescan, Inc. Analyte testing method and system
US8926551B2 (en) * 2009-07-07 2015-01-06 Baxter Healthcare Inc. Peritoneal dialysis therapy with large dialysis solution volumes
EA021945B1 (en) * 2009-07-08 2015-10-30 Уорлдуайд Иновейтив Нетуорк Method for predicting efficacy of drugs in a patient
US8751495B2 (en) * 2009-09-29 2014-06-10 Siemens Medical Solutions Usa, Inc. Automated patient/document identification and categorization for medical data
CN106228017A (en) * 2009-09-30 2016-12-14 帕斯维基因组学公司 Medication management system based on genome
US20100077349A1 (en) * 2009-11-06 2010-03-25 Health Grades, Inc. Patient direct connect
US20110112850A1 (en) * 2009-11-09 2011-05-12 Roberto Beraja Medical decision system including medical observation locking and associated methods
US20110184761A1 (en) * 2010-01-25 2011-07-28 Siemens Medical Solutions Usa, Inc. Method and Apparatus for Estimating Patient Populations
US10943676B2 (en) 2010-06-08 2021-03-09 Cerner Innovation, Inc. Healthcare information technology system for predicting or preventing readmissions
WO2012002435A1 (en) * 2010-06-30 2012-01-05 株式会社ニコン Infection spread prevention support system, infection spread prevention support server, examination terminal, mobile terminal and program
US20120016594A1 (en) * 2010-07-02 2012-01-19 Coriell Institute For Medical Research, Inc. Method for translating genetic information for use in pharmacogenomic molecular diagnostics and personalized medicine research
US20120078840A1 (en) * 2010-09-27 2012-03-29 General Electric Company Apparatus, system and methods for comparing drug safety using holistic analysis and visualization of pharmacological data
US20120101867A1 (en) * 2010-10-25 2012-04-26 Zgardovski Stanislav V System for Automatic Assignment of Agents in Inbound and Outbound Campaigns
US8719051B2 (en) * 2011-01-13 2014-05-06 Gear Five Health Solutions, Inc. System and method for evaluating and comparing medical treatments
US20140244292A1 (en) * 2011-01-27 2014-08-28 Wiser Together, Inc. Method for Helping Patients Find Treatments Based on Similar Patients' Experiences
EP2596449A1 (en) 2011-03-10 2013-05-29 Teva Pharmaceutical Industries Ltd. A method, system and program for improved health care
US20120239410A1 (en) * 2011-03-17 2012-09-20 Onmark, Inc. Method, apparatus and computer program product for developing cost-effective, evidence-based treatment pathways using a data-driven approach
US10057736B2 (en) 2011-06-03 2018-08-21 Apple Inc. Active transport based notifications
US20130018700A1 (en) * 2011-07-14 2013-01-17 International Business Machines Corporation Optimizing product portfolios under customer choice
WO2013076586A2 (en) 2011-11-21 2013-05-30 Advanced Biological Laboratories Sa Systems, methods, and computer program products for guiding the selection of therapeutic treatment regiments
WO2013093699A1 (en) * 2011-12-23 2013-06-27 Koninklijke Philips Electronics N.V. Creating a personalized patient pathway
EP2648121A1 (en) * 2012-04-03 2013-10-09 Koninklijke Philips N.V. Analyzing an action
CN103488858B (en) * 2012-06-15 2017-03-22 国家卫生计生委科学技术研究所 Contraception method selection expert evaluation method
US10593000B2 (en) * 2012-07-13 2020-03-17 Koninklijke Philips N.V. System and method for determining thresholds or a range of values used to allocate patients to a treatment level of a treatment program
US20140025393A1 (en) * 2012-07-17 2014-01-23 Kang Wang System and method for providing clinical decision support
US9727699B2 (en) * 2012-08-03 2017-08-08 Timeless Veterinary Systems Inc. Software tool for veterinarians
US20140156539A1 (en) * 2012-08-17 2014-06-05 CrowdCare Corporation Device Profile-Based Rule Making for Customer Care
US20140081659A1 (en) 2012-09-17 2014-03-20 Depuy Orthopaedics, Inc. Systems and methods for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking
US10403391B2 (en) 2012-09-28 2019-09-03 Cerner Health Services, Inc. Automated mapping of service codes in healthcare systems
US10318635B2 (en) 2012-09-28 2019-06-11 Cerner Innovation, Inc. Automated mapping of service codes in healthcare systems
US10565315B2 (en) 2012-09-28 2020-02-18 Cerner Innovation, Inc. Automated mapping of service codes in healthcare systems
KR101974258B1 (en) 2012-10-26 2019-04-30 백스터 코포레이션 잉글우드 Improved image acquisition for medical dose preparation system
CA2889352C (en) 2012-10-26 2021-12-07 Baxter Corporation Englewood Improved work station for medical dose preparation system
US9833191B2 (en) 2012-11-07 2017-12-05 Bigfoot Biomedical, Inc. Computer-based diabetes management
US10262756B2 (en) 2012-11-21 2019-04-16 Humana Inc. System for gap in care alerts
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US10383580B2 (en) 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US9579443B2 (en) 2013-01-10 2017-02-28 Fresenius Medical Care Holdings, Inc. Peritoneal dialysis systems and related devices and methods
US20140222512A1 (en) * 2013-02-01 2014-08-07 Goodsnitch, Inc. Receiving, tracking and analyzing business intelligence data
US20140229321A1 (en) 2013-02-11 2014-08-14 Facebook, Inc. Determining gift suggestions for users of a social networking system using an auction model
US9306896B2 (en) 2013-02-11 2016-04-05 Facebook, Inc. Delivery of messages for a life event of user of social networking system
AU2014233094B2 (en) 2013-03-15 2020-07-02 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
US20140343982A1 (en) * 2013-05-14 2014-11-20 Landmark Graphics Corporation Methods and systems related to workflow mentoring
CA2914534C (en) 2013-06-06 2023-07-18 Timeless Veterinary Systems Inc. Method and system for providing a treatment protocol
CN103258308A (en) * 2013-06-13 2013-08-21 宁飞鹏 Home system of medical care community
US10540448B2 (en) 2013-07-15 2020-01-21 Cerner Innovation, Inc. Gap in care determination using a generic repository for healthcare
US10726456B2 (en) 2013-07-15 2020-07-28 Aptitude, Llc Method, apparatus, and computer program product for providing a virtual aggregation group
US20150187228A1 (en) * 2013-12-24 2015-07-02 Precision Medicine Network, Inc. Interactive medical education method and system
US11257593B2 (en) 2014-01-29 2022-02-22 Umethod Health, Inc. Interactive and analytical system that provides a dynamic tool for therapies to prevent and cure dementia-related diseases
US10430555B1 (en) 2014-03-13 2019-10-01 Mckesson Corporation Systems and methods for determining and communicating information to a pharmacy indicating patient eligibility for an intervention service
WO2015143446A1 (en) * 2014-03-21 2015-09-24 The Regents Of The University Of California Nanomedicine optimization with feedback system control
US10133996B2 (en) * 2014-04-22 2018-11-20 International Business Machines Corporation Object lifecycle analysis tool
US10144976B2 (en) 2014-05-22 2018-12-04 Case Western Reserve University HIV-1 genotyping and coreceptor tropism assay
CN106456870B (en) 2014-06-10 2020-01-21 比格福特生物医学有限公司 Insulin delivery system and method
CA2961270A1 (en) * 2014-09-14 2016-03-17 League, Inc. System and method for health providers to deliver programs to individuals
US11107574B2 (en) 2014-09-30 2021-08-31 Baxter Corporation Englewood Management of medication preparation with formulary management
US10642957B1 (en) 2014-10-21 2020-05-05 Mckesson Corporation Systems and methods for determining, collecting, and configuring patient intervention screening information from a pharmacy
EP3937116A1 (en) 2014-12-05 2022-01-12 Baxter Corporation Englewood Dose preparation data analytics
CN107111856A (en) * 2014-12-22 2017-08-29 施曼信医疗Asd公司 Infusion planning system with clinical decision support
US10691774B2 (en) 2015-03-30 2020-06-23 Cambia Health Solutions, Inc. Systems and methods for a comprehensive online health care platform
US20180294051A1 (en) * 2015-04-29 2018-10-11 The University Of British Columbia Clinical support system and method
WO2016207206A1 (en) 2015-06-25 2016-12-29 Gambro Lundia Ab Medical device system and method having a distributed database
CN105512183B (en) * 2015-11-24 2019-10-11 中国科学院重庆绿色智能技术研究院 A kind of personalized recommendation method independently selected based on user and system
US20170193157A1 (en) * 2015-12-30 2017-07-06 Microsoft Technology Licensing, Llc Testing of Medicinal Drugs and Drug Combinations
EP3223181B1 (en) 2016-03-24 2019-12-18 Sofradim Production System and method of generating a model and simulating an effect on a surgical repair site
WO2017197492A1 (en) * 2016-05-20 2017-11-23 Appmed Inc. System and method for monitoring and identifying posology efficacy for an individual
US20180121616A1 (en) * 2016-10-28 2018-05-03 Pinscriptive, Inc. Systems and Methods for Treatment Decisions
US20180121617A1 (en) * 2016-10-28 2018-05-03 Pinscriptive, Inc. Treatment Decision Interface Device and Graphical User Interface (GUI)
WO2018114346A1 (en) 2016-12-21 2018-06-28 Gambro Lundia Ab Medical device system including information technology infrastructure having secure cluster domain supporting external domain
US10650380B1 (en) 2017-03-31 2020-05-12 Mckesson Corporation System and method for evaluating requests
US10839961B2 (en) 2017-05-05 2020-11-17 International Business Machines Corporation Identifying drug-to-drug interactions in medical content and applying interactions to treatment recommendations
US11404147B2 (en) 2017-05-05 2022-08-02 International Business Machines Corporation Treatment recommendations based on drug-to-drug interactions
CN107241429A (en) * 2017-06-30 2017-10-10 江西博瑞彤芸科技有限公司 Information interactive processing method and system
US11610688B2 (en) 2018-05-01 2023-03-21 Merative Us L.P. Generating personalized treatment options using precision cohorts and data driven models
US11232872B2 (en) 2018-06-06 2022-01-25 Reliant Immune Diagnostics, Inc. Code trigger telemedicine session
US10636527B2 (en) * 2018-06-06 2020-04-28 Reliant Immune Diagnostics, Inc. System and method for quantifying, ensuring, and triggering the prescriptive authority for a telemedicine session
CN109192262B (en) * 2018-09-17 2020-11-20 北京惠每云科技有限公司 Data transmission method and device
KR102293496B1 (en) * 2018-10-31 2021-08-26 재단법인대구경북과학기술원 System for cancer therapeutic recommendation using machine learning technique and method thereof
WO2020092756A1 (en) * 2018-11-01 2020-05-07 The Methodist Hospital System and method for automatically and continuously monitoring medication delivery to a patient
US11894139B1 (en) 2018-12-03 2024-02-06 Patientslikeme Llc Disease spectrum classification
CN109743363A (en) * 2018-12-18 2019-05-10 广州圆爱康生物科技有限公司 A kind of medical information intelligently pushing method and device
WO2020163441A1 (en) * 2019-02-06 2020-08-13 Optimdosing Llc Smart multidosing
CN110146704A (en) * 2019-03-28 2019-08-20 苏州举健生物科技有限公司 A kind of medication and pathological examination data system based on circulating tumor cell
CN111091908B (en) * 2019-11-19 2023-07-11 泰康保险集团股份有限公司 Auxiliary medical scheme generation method and device, storage medium and electronic equipment
US11488027B2 (en) 2020-02-21 2022-11-01 Optum, Inc. Targeted data retrieval and decision-tree-guided data evaluation
JP6893052B1 (en) * 2020-06-29 2021-06-23 ゲノム・ファーマケア株式会社 Dosing plan proposal system, method and program

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6014631A (en) * 1998-04-02 2000-01-11 Merck-Medco Managed Care, Llc Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry
US6021404A (en) * 1997-08-18 2000-02-01 Moukheibir; Nabil W. Universal computer assisted diagnosis
US6049794A (en) * 1997-12-09 2000-04-11 Jacobs; Charles M. System for screening of medical decision making incorporating a knowledge base

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868763A (en) * 1986-02-21 1989-09-19 Hitachi, Ltd. Knowledge-based system having plural processors
US4839822A (en) * 1987-08-13 1989-06-13 501 Synthes (U.S.A.) Computer system and method for suggesting treatments for physical trauma
JPH0271368A (en) * 1988-09-06 1990-03-09 Nec Corp Cancer remedy planning device
US5342922A (en) * 1989-03-08 1994-08-30 Washington University Inhibitors of retroviral protease
US5355444A (en) * 1990-01-23 1994-10-11 International Business Machines Corporation Expert system wtih a plurality of independent knowledge bases
JPH04166149A (en) * 1990-10-31 1992-06-12 Innovision Medical Inc Device for displaying electronic image of nonstationary object
US5299121A (en) * 1992-06-04 1994-03-29 Medscreen, Inc. Non-prescription drug medication screening system
US5694950A (en) * 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
SE500122C2 (en) * 1992-08-27 1994-04-18 Rudolf Valentin Sillen Method and apparatus for individually controlled, adaptive medication
US5517405A (en) * 1993-10-14 1996-05-14 Aetna Life And Casualty Company Expert system for providing interactive assistance in solving problems such as health care management
US5660176A (en) * 1993-12-29 1997-08-26 First Opinion Corporation Computerized medical diagnostic and treatment advice system
US5594638A (en) * 1993-12-29 1997-01-14 First Opinion Corporation Computerized medical diagnostic system including re-enter function and sensitivity factors
US5737539A (en) * 1994-10-28 1998-04-07 Advanced Health Med-E-Systems Corp. Prescription creation system
US5845255A (en) * 1994-10-28 1998-12-01 Advanced Health Med-E-Systems Corporation Prescription management system
US5649070A (en) * 1995-02-17 1997-07-15 International Business Machines Corporation Learning system with prototype replacement
US5911132A (en) * 1995-04-26 1999-06-08 Lucent Technologies Inc. Method using central epidemiological database
EP0879449A2 (en) * 1996-02-09 1998-11-25 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
US6108635A (en) * 1996-05-22 2000-08-22 Interleukin Genetics, Inc. Integrated disease information system
US5924074A (en) * 1996-09-27 1999-07-13 Azron Incorporated Electronic medical records system
US5950630A (en) * 1996-12-12 1999-09-14 Portwood; Michael T. System and method for improving compliance of a medical regimen
US5908383A (en) * 1997-09-17 1999-06-01 Brynjestad; Ulf Knowledge-based expert interactive system for pain
AU750822B2 (en) * 1998-04-03 2002-08-01 Triangle Pharmaceuticals, Inc. Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6021404A (en) * 1997-08-18 2000-02-01 Moukheibir; Nabil W. Universal computer assisted diagnosis
US6049794A (en) * 1997-12-09 2000-04-11 Jacobs; Charles M. System for screening of medical decision making incorporating a knowledge base
US6014631A (en) * 1998-04-02 2000-01-11 Merck-Medco Managed Care, Llc Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1068568A2 *

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1437674B2 (en) 1998-11-30 2011-11-23 Novo Nordisk A/S A method for assisting a user in a medical self treatment
EP1437674A2 (en) 1998-11-30 2004-07-14 Novo Nordisk A/S A method and a system for assisting a user in a medical self treatment
US6581038B1 (en) * 1999-03-15 2003-06-17 Nexcura, Inc. Automated profiler system for providing medical information to patients
JP2001273362A (en) * 2000-03-23 2001-10-05 Toshiba Corp Medical diagnosis supporting method, system therefor, retrieval terminal and medical information terminal for the same
JP2001293058A (en) * 2000-04-14 2001-10-23 Takeo Kawai Method and apparatus for indicating treatment data in musculature zone remedy
JP2009123233A (en) * 2001-12-28 2009-06-04 Lahteenmaki Pertti System and method for providing recommendation and/or information concerning suitability for nutritional and/or medical ingredients
US10173008B2 (en) 2002-01-29 2019-01-08 Baxter International Inc. System and method for communicating with a dialysis machine through a network
US10556062B2 (en) 2002-01-29 2020-02-11 Baxter International Inc. Electronic medication order transfer and processing methods and apparatus
WO2004015612A1 (en) * 2002-07-31 2004-02-19 Otto Carl Gerntholtz Infectious disease surveillance system
US7840421B2 (en) 2002-07-31 2010-11-23 Otto Carl Gerntholtz Infectious disease surveillance system
US9050411B2 (en) 2003-11-05 2015-06-09 Baxter International Inc. Dialysis system including downloaded prescription entry
US9675745B2 (en) 2003-11-05 2017-06-13 Baxter International Inc. Dialysis systems including therapy prescription entries
US9081879B2 (en) 2004-10-22 2015-07-14 Clinical Decision Support, Llc Matrix interface for medical diagnostic and treatment advice system and method
EP2109056A3 (en) * 2008-04-08 2010-07-21 The Quantum Group, Inc. System and method for dynamic drug interaction analysis and reporting
EP2109056A2 (en) * 2008-04-08 2009-10-14 The Quantum Group, Inc. System and method for dynamic drug interaction analysis and reporting
US9690905B2 (en) 2008-07-09 2017-06-27 Baxter International Inc. Dialysis treatment prescription system and method
US10561780B2 (en) 2008-07-09 2020-02-18 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US10272190B2 (en) 2008-07-09 2019-04-30 Baxter International Inc. Renal therapy system including a blood pressure monitor
US10265455B2 (en) 2008-07-09 2019-04-23 Baxter International Inc. Dialysis system including wireless sensor data
US9697334B2 (en) 2008-07-09 2017-07-04 Baxter International Inc. Dialysis system having approved therapy prescriptions presented for selection
US10224117B2 (en) 2008-07-09 2019-03-05 Baxter International Inc. Home therapy machine allowing patient device program selection
US10016554B2 (en) 2008-07-09 2018-07-10 Baxter International Inc. Dialysis system including wireless patient data
US10061899B2 (en) 2008-07-09 2018-08-28 Baxter International Inc. Home therapy machine
US10068061B2 (en) 2008-07-09 2018-09-04 Baxter International Inc. Home therapy entry, modification, and reporting system
US10095840B2 (en) 2008-07-09 2018-10-09 Baxter International Inc. System and method for performing renal therapy at a home or dwelling of a patient
US8548937B2 (en) 2010-08-17 2013-10-01 Wisercare Llc Medical care treatment decision support system
US20130179181A1 (en) * 2012-01-06 2013-07-11 Molecular Health Systems and methods for personalized de-risking based on patient genome data
US9779214B2 (en) * 2012-01-06 2017-10-03 Molecular Health Gmbh Systems and methods for personalized de-risking based on patient genome data
EP2845140A1 (en) * 2012-04-02 2015-03-11 MOLECULAR HEALTH GmbH Systems and methods for disease knowledge modeling and clinical decision support
WO2013150039A1 (en) * 2012-04-02 2013-10-10 Molecular Health Ag Systems and methods for disease knowledge modeling and clinical decision support
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
WO2014117873A1 (en) * 2013-01-29 2014-08-07 Molecular Health Ag Systems and methods for clinical decision support
US10672514B2 (en) 2013-01-29 2020-06-02 Molecular Health Gmbh Systems and methods for clinical decision support
US10589014B2 (en) 2016-12-21 2020-03-17 Baxter International Inc. Medical fluid delivery system including remote machine updating and control
US10905811B2 (en) 2016-12-21 2021-02-02 Baxter International Inc. Medical fluid delivery system including remote machine updating and control
US10964417B2 (en) 2016-12-21 2021-03-30 Baxter International Inc. Medical fluid delivery system including a mobile platform for patient engagement and treatment compliance
US11393565B2 (en) 2016-12-21 2022-07-19 Baxter International Inc. Medical fluid delivery system including a mobile platform for patient engagement and treatment compliance
US11458232B2 (en) 2016-12-21 2022-10-04 Baxter International Inc. Medical fluid delivery system including remote machine updating and control
US11696977B2 (en) 2016-12-21 2023-07-11 Baxter International Inc. Medical fluid delivery system including remote machine updating and control

Also Published As

Publication number Publication date
EP1068568A4 (en) 2004-10-27
US6188988B1 (en) 2001-02-13
CA2326579C (en) 2011-01-18
JP4764500B2 (en) 2011-09-07
AU750822B2 (en) 2002-08-01
CN1304512A (en) 2001-07-18
EP1068568A2 (en) 2001-01-17
US6081786A (en) 2000-06-27
JP2002510817A (en) 2002-04-09
WO1999052025A3 (en) 1999-12-02
BR9909906A (en) 2000-12-26
CA2326579A1 (en) 1999-10-14
JP2010020784A (en) 2010-01-28
IL138620A0 (en) 2001-10-31
AU3461799A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
US6081786A (en) Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
Zaugg et al. Providing physicians with feedback on medication adherence for people with chronic diseases taking long‐term medication
Carson‐Chahhoud et al. Community pharmacy personnel interventions for smoking cessation
Pande et al. The effect of pharmacist‐provided non‐dispensing services on patient outcomes, health service utilisation and costs in low‐and middle‐income countries
Lawrenson et al. Interventions to increase attendance for diabetic retinopathy screening
Singh et al. Belimumab for systemic lupus erythematosus
McLean et al. Telehealthcare for chronic obstructive pulmonary disease
Glynn et al. Interventions used to improve control of blood pressure in patients with hypertension
Dyakova et al. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease
Gillaizeau et al. Computerized advice on drug dosage to improve prescribing practice
Braun et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults
Preston et al. Blood transfusions for anaemia in patients with advanced cancer
US20020111832A1 (en) Method and apparatus for delivering a pharmaceutical prescription copay counselor over an internet protocol network
Freemantle et al. Implementing findings of medical research: the Cochrane Collaboration on Effective Professional Practice.
Ansari et al. Hydroxyurea (hydroxycarbamide) for transfusion‐dependent β‐thalassaemia
Pant Pai et al. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults
Brigo et al. Zonisamide add‐on therapy for focal epilepsy
Mellon et al. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients
Bresnahan et al. Tiagabine add‐on therapy for drug‐resistant focal epilepsy
Bhattacharya et al. Directive Explanations for Monitoring the Risk of Diabetes Onset: Introducing Directive Data-Centric Explanations and Combinations to Support What-If Explorations
Belthangady et al. Causal deep learning reveals the comparative effectiveness of antihyperglycemic treatments in poorly controlled diabetes
AU2002221800A1 (en) Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
MXPA00009719A (en) Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
Lu et al. A clinical decision support system design framework for nursing practice
Ekhart Taking down malicious webshops: designing Explainable AI against growing e-commerce fraud

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99806991.4

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 34617/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2000/00422/MU

Country of ref document: IN

Ref document number: 138620

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2326579

Country of ref document: CA

Ref document number: 2326579

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 542701

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/009719

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1999916262

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999916262

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 34617/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1556/DELNP/2004

Country of ref document: IN

WWR Wipo information: refused in national office

Ref document number: 1999916262

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999916262

Country of ref document: EP